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 ABSTRACT 
 
Lipids are the predominant source of energy for fish. The mechanisms by which fish 
allocate energy from lipids, for metabolism, development, growth and reproduction are 
critical for understanding key life history strategies and transitions. Currently, the major 
lipid component in aquaculture diets is fish oil (FO), derived from wild capture fisheries 
that are exploited at their maximum sustainable limit. The increasing demand from 
aquaculture for FO will soon exceed supply and threaten the viability of aquaculture. 
Thus, it is essential to minimize FO use in aquaculture diets. This might be achieved by a 
greater understanding of lipid storage and muscle growth, or the identification of 
alternatives to FO in feeds. This review focuses on recent research applying molecular 
and genomic techniques to the study of fin-fish lipid metabolism from an aquaculture 
perspective. Accordingly, particular emphasis will be given to fatty acid metabolism and 
to highly unsaturated fatty acid (HUFA) biosynthesis, and to the transcriptional 
mechanisms and endocrine factors that regulate these processes in fish. Comparative 
studies of gene function and distribution are described which, when integrated with 
recent fish genome sequence information, provide insights into lipid homeostasis and the 
outcomes associated with the replacement of FO in fish diets. 
 
Keywords fatty acid, sea bream, Atlantic salmon, desaturase, elongase, metabolism, 
PPARs, ghrelin, endocrinology. 
 
INTRODUCTION 
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The noun lipid refers to a large and heterogeneous group of substances classified 
together on the basis of their high solubility in non-polar solvents or their relatedness to 
such compounds. The vast majority of lipids in eukaryotes are derived from acetyl-CoA 
and belong to three major classes: straight chain fatty acids, branched, cyclic and other 
specialised fatty acids, and polyprenoid compounds including carotenoids and sterols and 
their derivatives. Lipids have a number of major roles in all organisms. Perhaps most 
importantly they are structural components of cell membranes and they are essential for 
energy provision and storage. Lipids and fatty acids, along with proteins, are the major 
macronutrients for fish (Sargent et al.  2002). Fish seem not to have evolved efficient 
carbohydrate utilization systems in contrast to terrestrial vertebrates where carbohydrates, 
originating from plant-derived foodstuffs, are major components of the diet of many 
organisms. Thus, carbohydrates are quantitatively of little importance as nutrients for 
most fish, suggesting that fish may satisfy structural carbohydrate and storage 
carbohydrate (glycogen) requirements principally by catabolising amino acids (Cowey 
and Walton, 1989). Fish are also the most diverse and numerous members of the 
vertebrates and have a correspondingly diverse array of life history strategies. The 
mechanisms by which fish allocate energy, from lipids and protein, to development, 
growth and reproduction are of critical importance in understanding these life history 
strategies.Ultimately a greater understanding of these mechanisms will guide sustainable 
fisheries and aquaculture activities. 
The growth in fin-fish aquaculture has been made possible by the development of 
artificial diets or feeds formulated to satisfy essential requirements (amino acids, fatty 
acids, vitamins and minerals etc), and provide macronutrients (protein, lipid, 
carbohydrate) and energy in balance to optimise growth. Thus, it has been the 
requirements of aquaculture that have driven research into fish nutrition including lipid 
and fatty acid metabolism and its regulation. Dietary lipid and fatty acids can have three 
primary fates in fish. They can be incorporated into cell membranes and hence the flesh 
of the fish, they can be oxidised to provide energy, or lipid can be deposited in adipose or 
other tissues as energy storage (Tocher, 2003). Therefore, from an aquaculture 
perspective, the lipid (fat) content and the fatty acid composition of the diet must be 
optimised to enable high growth rates, ensure fish health and, at the same time, maintain 
the nutritional benefits of fish for the human consumer (Sargent et al.  2002; Tocher, 
2003). 
The lipid content of pelleted diets has increased greatly in recent years due in part 
to the technical advancements in the production of feed. This increase is driven by the 
observation that the more energy that can be supplied by dietary lipid, the less protein 
will be used for energy and so more dietary protein can be “spared” for synthesis of new 
tissue/flesh (Hemre and Sandnes, 1999). However, although protein sparing by dietary 
lipid is widely accepted, the limits to its effectiveness, or the mechanisms by which it 
might occur, have not been accurately defined for any fish (see Company et al.  1999). 
Consequently, dietary formulations have maximised lipid content in order to satisfy 
commercial pressure to increase growth rates and reduce production times, despite the 
fact that there is a strong relationship between dietary lipid levels and undesirable levels 
of lipid in the carcass of fish (Cowey and Cho, 1993). 
The specific fatty acid composition of fish diets, and indeed human diets, is also 
of critical importance. Fish have a varying requirement, depending on the species, for n-3 
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or ω3 long-chain polyunsaturated fatty acids (PUFA), eicosapentaenoic acid (EPA; 
20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3), sometimes referred to as n-3 HUFA 
(highly unsaturated fatty acids; Henderson and Sargent, 1984). Humans have a limited 
capacity to synthesise n-3 HUFA from shorter chain precursors, and fish have become 
vitally important as the only significant source of n-3 HUFA, particularly in the Western 
foodbasket. Fish oil, rich in n-3 HUFA and derived from industrial fisheries, e.g. capelin, 
herring, sand eel, mackerel, anchovy and sardine, has been the standard ingredient of 
bulk feeds for intensively farmed fish. The strict requirements of marine fish for n-3 
HUFA make fish oil (FO) the only commercially available source of these essential fatty 
acids in marine fish feeds. Until recently the ready availability and relatively low cost of 
FO has resulted in its widespread use in farmed fish feeds. However, global fisheries 
have now reached their sustainable limits and the current yield of FO from industrial 
fisheries, circa 1.4 million tonnes in 1996 (Sargent and Tacon, 1999), is unlikely to be 
significantly exceeded in future (Tacon, 2004; Pike, 2005). It is clear that the increasing 
demand from aquaculture for FO will soon exceed supply and threaten the viability of 
fish farming activities as well as wild fish stocks. For these reasons, identifying suitable 
alternatives to FO in farmed fish feeds or improving efficiency of FO use are becoming 
increasingly urgent issues. A variety of oils, particularly those derived from plant oil-
seeds (vegetable oils, VO) are available, however any dietary alternative to FO must 
address the issues of balancing lipid storage with lipid burning for growth and supplying 
essential fatty acids, whilst maintaining the health of the fish. 
This review will focus on recent research applying molecular and genomic 
techniques to the study of fin-fish lipid metabolism from an aquaculture perspective. 
Accordingly, major emphasis will be given to fatty acid metabolism and to HUFA 
biosynthesis, as well as to the potential transcriptional mechanisms and factors that 
regulate these processes in fish. To this end, a comparative approach to mammalian fatty 
acid metabolism is inevitable. Although this review is focused on aquaculture species, 
stressing, the similarities and differences between these species in lipid biosynthesis, 
metabolism and storage, it also attempts to integrate relevant information stemming from 
genome-wide data available from sequenced fish genomes. 
 
FATTY ACID METABOLISM 
 
Lipogenesis 
 
Lipogenesis in fish is considered to be essentially an identical process to that in mammals 
(Sheridan, 1994) and the metabolic steps are summarized in Figure 1. Thus acetyl-CoA is 
activated to malonyl-CoA by acetyl-CoA carboxylase (ACC) and iteratively assembled in 
the cytosol by fatty acid synthase (FAS) to form 16 and 18 carbon saturated fatty acids. 
This process requires considerable reducing power in the form of NADPH which is 
supplied by the dehydrogenases of the pentose phosphate shunt (principally glucose 6-
phosphate dehydrogenase, G6PD) and malic enzyme (ME). Thus pivotal flow through 
lipogenesis is controlled by two limiting supplies, NADPH and malonyl-CoA. The 
cellular content of G6PD and ME varies markedly depending upon dietary and hormonal 
conditions. In Atlantic salmon (Salmo salar), under standard diets, ME is the major 
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contributor (Menoyo et al.  2003) whereas in gilthead sea bream (Sparus aurata, 
hereafter sea bream), NADPH is mainly provided by G6PD (Menoyo et al.  2004).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic view of the main pathways of dietary fuel metabolism in fish liver. Some major 
metabolites are indicated and important enzymes discussed in the text are boxed. Open arrows indicate 
anabolic pathways and normal arrows catabolic routes. Diet provides fatty acids that can be directly stored 
in adipose tissue or enter into the hepatic pathways for energy generation though β-oxidation in 
peroxisomes or mitochondria. The highly regulated lipoprotein lipase (LPL) is a main distributor of the fate 
of fatty acids. The carnitine palmitoyl tranferase system (CPT) in the mitochondrial membrane is the 
limiting step in the energy use from fatty acids into the mitochondria, whilst acetyl CoA-oxidase (ACO) is 
a major enzyme of fatty oxidation in peroxisomes. Lipid biosynthesis (and many other biosynthetic 
pathways) is driven by the acetyl-CoA-carboxylase (ACC) and fatty acid synthase (FAS) coupled system 
which is nourished by NADPH through the pentose-phosphate shunt at glucose-6-phosphate dehydrogenase 
(G6PD) and by the activity of malic enzyme (ME). Highly unsaturated, polyunsaturated and 
monounsaturated fatty acids (HUFA, PUFA and MUFA respectively) are synthesized from cellular fatty 
acid intermediates (e.g. palmitate) and from dietary fatty acids though fatty acid elogase (ELO) and 
desaturase (DES). Dietary amino acids can be oxidized to intermediates which can enter gluconeogenic 
pathways, ultimately for energy storage as glycogen or for NADPH production. 
 
Saturated 16:0 and 18:0 fatty acids assembled by FAS can then be desaturated initially by 
stearoyl CoA deasurase to form 16:1n-7 and 18:1n-9. These monounsaturates may be 
further desaturated and elongated by specific fatty acyl desaturases and elongases, 
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especially under conditions of essential fatty acid deficiency (see section 2.5.1 Fatty acyl 
desaturases). Changes in hepatic G6PD activity levels in Atlantic salmon fed VO based 
diets have been connected with increases in these fatty acid elongation and desaturation 
processes which require NADPH  (Menoyo et al.  2005; Zheng et al.  2004b). 
Substitution of FO for VO in fish diets has been shown to affect lipogenesis. In fish, 
relative NADPH contribution by ME and G6PD is controlled by the presence of 
particular fatty acids that modify their specific activities. Thus, EPA and DHA inhibit 
lipogenesis in salmonids in vivo and in vitro (Menoyo et al.  2003; Alvarez et al.  2000) 
indicating that the HUFA components of FO tend to repress hepatic lipogenic enzymes. 
Atlantic salmon in both fresh water and sea water stages (Jordal et al.  2007), exhibit 
lower hepatic triacylglycerol levels in FO compared to VO fed fish.. Simlarly, VO 
inclusion in Atlantic salmon diets results in increased liver lipid and up-regulation of the 
glucose transporter GLUT4 expression in muscle, with concomitant modifications of 
plasma triglyceride and glucose levels (Menoyo et al.  2006). In sea bream the inclusion 
of VO in the diet reduces the n-3 PUFA levels in muscle and this is in turn associated 
with a higher liver lipid deposition (Menoyo et al.  2004). The mechanism by which 
dietary fat type affects fat deposition and glucose metabolism in fish are not known, but 
somatolactin and growth hormone have been shown to inhibit ACC in sea bass 
highlighting the importance of hormones in regulating these processes (De Celis et al.  
2003). However, although there are indications of alterations in patterns of lipid 
deposition, in general the substitution of FO by VO has no drastic effects on lipogenesis. 
This is probably because the dietary supply of fat is high in aquaculture diets. Notably, 
rainbow trout (Oncorhynchus mykiss) liver and intestine ACC activity is decreased by 
high lipid diets (Rollin et al.  2003). For these reasons there have been very few 
molecular studies specifically targeting lipogenesis in fish. 
 
Lipoprotein Lipase 
 
The fate of endogenously synthesised fatty acids is predominantly structural and 
as energy storage. All fish, store lipids in viscera, liver and muscle tissues (Zhou et al.  
1995; Jobling and Johansen, 2003; Nanton et al.  2007). Most lipogenesis occurs in the 
liver and adipose cells and transport of lipid between these stores and to tissues is 
accomplished by assembly and excretion followed by disassembly and uptake of plasma 
lipoproteins. Lipoprotein lipase (LPL) is an important enzyme in this process and its 
differential regulation across different tissues is critical to the balance between fat 
accumulation and fat catabolism (Fig. 1). LPL activity is promoted in adipose tissue by 
hormones such as insulin, and depressed in muscle by, for example, catecholamines. 
Thus the activity of LPL can be regulated reciprocally between muscle and adipose tissue 
so as to favour either energy production or storage of TG (Mead et al.  2002). Several 
LPL genes have been identified in fish (Lindberg and Olivecrona, 2002; Saera-Vila et al.  
2005; Oku et al.  2002). The four LPL genes found in red sea bream (Pagrus major), 
named LPL1, LPL2, HL (hepatic lipase) and PL (pancreatic lipase) have a high degree of 
sequence similarity. LPL1 and LPL2 genes are ubiquitously expressed but HL is 
exclusively expressed in hepatic tissue and PL in hepatopancreas and adipose tissue. The 
ubiquitous LPL1 and LPL2 genes are regulated in a tissue-specific manner in response to 
the nutritional state of fish (Oku et al.  2006), and recently some knowledge on how 
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nutritional and seasonal status and hormones affect these genes have been obtained in 
several fish. Starvation increases, and dietary fatty acids differentially regulate LPL 
expression in red sea bream liver and adipose tissue (Liang et al.  2002; Oku et al.  2006). 
In rainbow trout adipose LPL activity is regulated by insulin with tissue-specific 
modulation following food intake (Albalat et al.  2006). Moreover, TNFα, a cytokine 
with many biological functions that in mammals modulates muscle and adipose tissue 
metabolism, plays an important role in the control of lipid metabolism in rainbow trout 
by down-regulating adipose tissue LPL activity and also by stimulating lipolysis (Albalat 
et al.  2006). Seasonal- and nutritional-dependent tissue-specific regulation of ubiquitous 
LPL also occurs in gilthead sea bream (Saera-Vila et al.  2005). In these studies, maximal 
expression of LPL was found in mesenteric adipose tissue and up-regulation of this gene 
in spring coincides with a pronounced increase of whole body fat content. In contrast, in 
summer skeletal muscle LPL expression peaks to facilitate the increased energy demands 
for muscle growth through structural protein accumulation (Saera-Vila et al.  2005). 
These studies have underlined the importance of endocrine control of fish energy 
homeostasis, which regulates lipid catabolism as a response to different seasonal or 
nutritional situations.  
 
Beta-oxidation of Fatty Acids 
 
The catabolism of fatty acids can occur by β-oxidation in two different organelles 
in the cells, mitochondria and peroxisomes (Fig. 1). Red muscle, liver and heart are 
generally regarded as the most important tissues for β-oxidation in fish (reviewed by 
(Henderson and Tocher, 1987). However, although having a low β-oxidation capacity per 
gram of tissue, white muscle has been shown to be the major site for β-oxidation due to 
the overall size of the tissue (Froyland et al.  2000; Nanton et al.  2003; Stubhaug et al.  
2005). The capacity for fish to catabolise fatty acids depends on various factors such as 
fish size, life stage and season with especially smoltification in Atlantic salmon having a 
major impact on β-oxidation capacity in liver and red muscle (Stubhaug et al.  2006). 
Carnivorous fish rely mainly on protein and lipids for energy rather than carbohydrates. 
The relative importance of dietary lipid for energy production compared to protein is 
dependent on dietary lipid level with high dietary lipid having a protein sparing effect 
(Hemre and Sandnes, 1999). 
Peroxisomal β-oxidation resembles mitochondrial β-oxidation, however different 
enzymes perform the various reactions and consequently half of the energy produced 
from peroxisomal β-oxidation is lost as heat compared to mitochondrial β-oxidation. The 
importance of mitochondrial or peroxisomal β-oxidation is dependent on tissue. Typically 
in fish liver peroxisomal β-oxidation contributes significantly to the total β-oxidation 
capacity (Crockett and Sidell, 1993; Nanton et al.  2003), and contributes up to 100% of 
the total β-oxidation during the parr-smolt transformation (Stubhaug et al.  2007). The 
contribution from peroxisomal β-oxidation is low and less than 10% of the total in both 
white- and red muscle in Atlantic salmon, but increases up to 60% in red muscle during 
Atlantic salmon parr-smolt transformation (Stubhaug et al.  2007). Acyl-CoA oxidase 
(ACO, Fig. 1) catalyzes the rate limiting step in the peroxisomal β-oxidation system 
(Inestrosa et al.  1979). ACO genes have been studies in fish and are similar in sequence 
and tissue expression to their mammalian counterparts. Notably, expression of ACO in 
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rainbow trout is nutritionally regulated, with intestinal mRNA levels rising in response to 
feeding (Morais et al.  2007). Given the importance of peroxisomal β-oxidation in 
Atlantic salmon, several studies have attempted to investigate ACO activity in liver (see 
later section on PPARα) and in general these studies have not shown large changes, 
either after FO substitution or after feeding compounds shown to be modulators of ACO 
activity in rodents (Henderson and Sargent, 1984; Donohue et al.  1993; Ruyter et al.  
1997). A notable exception occurs during the Atlantic salmon parr-smolt transformation 
where VO-fed fish had significantly decreased β-oxidation capacity compared to FO-fed 
fish (Stubhaug et al.  2007). Also of interest is the finding that feeding of sea bream with 
conjugated linoleic acid (CLA)-supplemented FO diets (Diez et al.  2007) stimulated a 
large postprandial (6 hours after feeding) increase in ACO activity compared to FO alone 
and furthermore this effect was accompanied by a decrease in a marker of mitochondrial 
β-oxidation, L-3-hydroxyacyl-CoA dehydrogenase. Interestingly these effects of CLA on 
sea bream were not observed 24 hours after feeding, indicating that the measurement of 
postprandial effects should be given more attention in future FO replacement 
experiments. 
Replacing dietary FO with plant oils and thus significantly changing the dietary 
and tissue fatty acid composition may also influence the β-oxidation capacity (Torstensen 
and Stubhaug, 2004; Stubhaug et al.  2006; Stubhaug et al.  2007). These studies suggest 
that there are β-oxidation substrate preferences for some fatty acids which differ between 
fish fed FO and VO. The mechanisms of these dietary induced changes in β-oxidation in 
fish are unknown. 
 
Carnitine palmitoyl transferase 
 
To enable mitochondrial β-oxidation of the activated fatty acid, acyl-CoAs have 
to reach the inner compartment of the mitochondria. Carnitine palmitoyl transferase-1 
(CPT1, Fig.1) in the outer mitochondria membrane converts acyl-CoA to acyl-carnitine, 
which is then transported over the inner mitochondrial membrane in exchange with a free 
carnitine molecule. Inside the mitochondrial matrix acyl-carnitine is converted back to 
acyl-CoA by the action of carnitine palmitoyl transferase-2 (CPT2), and the acyl-CoA is 
then β-oxidised. Generally, the key point in the regulation of mitochondrial β-oxidation is 
thought to be CPT1, which can be inhibited by malonyl-CoA. Since the synthesis of 
malonyl-CoA is the first committed step in de novo fatty acid biosynthesis, the 
concentration-dependent inhibition of CPT1 by malonyl-CoA provides a direct 
mechanism to control the balance between lipogenesis and mitochondrial β-oxidation 
(Bremer, 1997). In addition to inhibition by malonyl-CoA, CPT1 activity is significantly 
regulated at the gene level as a response to nutritional stimuli such as fatty acids and 
feeding and fasting (Brandt et al.  1998; Leone et al.  1999). In mammals, CPT1 exists as 
at least two isoforms, one being expressed predominantly in the liver (CPT1A) and the 
second (CPT1B) in the skeletal muscle. A third more distantly related isoform of the 
enzyme (CPT1C) of unknown function and whose expression is restricted to the central 
nervous system, has been recently described in mammals (Van Der Leij et al.  2000; 
Price et al.  2002). The genetics underlying the CPT system in fish have recently attracted 
some attention. A cDNA encoding the apparent CPT1B orthologue of rainbow trout has 
been reported (Gutieres et al.  2003). Although the inhibition of CPT1 by malonyl-CoA 
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has been confirmed for Atlantic salmon (Froyland et al.  1998) and rainbow trout 
(Gutieres et al.  2003), the data presently available for the regulation of this enzyme at the 
gene level in fish are limited. Hepatic CPT1 activity and mRNA expression have been 
reported not to be affected by dietary CLA in Atlantic salmon, despite a significant 
increase in peroxisomal β-oxidation in the liver as a response to this treatment (Leaver et 
al.  2006). In contrast, in red muscle CPT1 activity and mRNA levels significantly 
decreased with dietary CLA intake (Leaver et al.  2006). Furthermore, we have also 
observed a significant post-prandial decrease of CPT1B mRNA levels in the sea bream 
heart (M. J. Leaver and G. Krey, unpublished).  
Although CPT2 may also act as an important regulation site in rodent lipid 
metabolism (Willumsen et al.  1996; Madsen and Berge, 1999), this gene and its product 
have not been studied in fish. The same also holds for a variety of other enzymes 
important for mitochondrial β-oxidation and energy transduction, such as the long-chain 
acyl-CoA-dehydrogenase, a key enzyme of mitochondrial β-oxidation of unsaturated 
fatty acids (Le et al.  2000). It is evident that the molecular aspects of mitochondrial β-
oxidation must be more thoroughly examined in fish. 
 
Biosynthesis of Highly Unsaturated Fatty Acids 
 
All organisms are capable of lipogenesis, that is, the synthesis of saturated fatty 
acids, and the production of monounsaturated fatty acids (such as 18:1n-9) via the action 
of ∆9 desaturases.  However, only plants (and a few invertebrates) have the ∆12 and ∆15 
(ω3) desaturases necessary to further desaturate 18:1n-9 to form the polyunsaturated 
fatty acids (PUFA), 18:2n-6 and 18:3n-3, respectively. Therefore, PUFA are essential in 
the diet of vertebrates as precursors of the physiologically essential HUFA; EPA, DHA 
and arachidonic acid (ARA; 20:4n-6). In vertebrates, biosynthesis of HUFA can proceed 
by sequential desaturation and elongation of 18:2n-6 and 18:3n-3 in the endoplasmic 
reticulum.  Synthesis of ARA is achieved by ∆6 desaturation of 18:2n-6 to produce 
18:3n-6 that is elongated to 20:3n-6 and finally desaturated at the ∆5 position to produce 
ARA (Fig 2.; Cook, 1996). The pathway for EPA synthesis from 18:3n-3 is essentially 
similar but, for DHA synthesis, the insertion of the last ∆4 ethylenic bond does not occur 
through direct ∆4 desaturation. Rather, EPA undergoes two rounds of elongation to form 
24:5n-3 which then undergoes ∆6 desaturation (∆6*) to 24:6n-3 followed by a chain 
shortening reaction in the peroxisomes, to 22:6n-3 (Fig.2; Sprecher, 2000). 
The extent to which fish can convert C18 PUFA to C20/22 HUFA varies, associated 
with their complement of fatty acid desaturase and elongase enzymes.  Freshwater fish 
are capable of producing DHA from 18:3n-3 and so presumably express all the 
desaturase and elongase activities necessary for this biosynthetic pathway (Sargent et al.  
2002).  In contrast, marine fish are unable to produce DHA from 18:3n-3 at a 
physiologically significant rate (Sargent et al.  2002) due to deficiencies in one or more 
steps in the pathway (Tocher, 2003).  These differences in the capacity of fish to 
synthesise HUFA appear to be evolutionarily related to the nature of the fatty acid 
profiles present in their respective diets.  Thus, freshwater fish, whose diets are based on 
the terrestrial food chain which is generally lower in HUFA and particularly DHA, 
convert 18:2n-6 and 18:3n-3 to HUFA more efficiently than do marine species whose 
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diet is rich in both EPA and DHA characteristic of the phytoplanktonic organisms on 
which the marine food chain is built  (Sargent et al.  2002; Tocher, 2003). The 
consequence is that 18:2n-6 and 18:3n-3 can satisfy essential fatty acid (EFA) 
requirements in freshwater fish, whereas EPA and DHA are the required essential fatty 
acids in marine fish (Sargent et al.  2002). 
 
Figure 2.The highly unsaturated fatty acid 
biosynthesis pathway in vertebrates. 
Schematic pathway showing the enzymes and 
intermediate fatty acids catalysing and leading to 
the predominant products of highly unsaturated 
fatty acid synthesis in vertebrates. ARA, 
arachidonic acid; EPA, eicosapentenoic acid and 
DHA, docosahexenoic acid. 
 
 
 
 
 
 
 
Aquaculture supplies an increasing proportion of the fish in the human food 
basket, up to 43% in 2005 (FAO, 2006). So far artificial diets, traditionally based on FO, 
have ensured that farmed fish, particulary of marine origin, are rich in n-3 HUFA.  The 
principal sustainable alternatives to FO are numerous plant-derived VO, which can be 
rich in C18 PUFA, but lack the n-3HUFA abundant in FO (Sargent et al.  2002). Thus, 
flesh fatty acid compositions of fish fed VO are characterised by increased levels of 
18:2n-6 and 18:3n-3, and decreased levels of n-3 HUFA, compromising their nutritional 
value to the human consumer (Izquierdo et al.  2003; Regost et al.  2003). The primary 
objectives in applying genomic and molecular technologies to this area are to identify the 
genes encoding HUFA biosynthetic enzymes, to determine how they are regulated and 
how their expression can be optimised to enable fish to make effective use of dietary VO. 
 
Fatty acyl desaturases 
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Mammals possess separate genes for ∆5 and ∆6 desaturases (Marquardt et al.  
2000) and can produce DHA from 18:3n-3 endogenously, albeit at low levels (Bezard et 
al.  1994). These genes encode endoplasmic reticulum bound proteins, each of around 
52kDa, which act as the substrate-specific terminal components of an electron transport 
system. They have a requirement for NADPH and molecular oxygen and insert double 
bonds between the carboxyl end and the first pre-existing double bond of fatty acids of 
between 16 and 24 carbons, a characteristic which accounts for the name “front-end” 
desaturases  (Tocher et al.  1998). The protein sequences of the fish desaturases possess 
all the characteristic features of microsomal fatty acid front-end desaturases from other 
organisms, including three histidine boxes, two transmembrane regions, and an N-
terminal cytochrome b5 domain containing the haem-binding motif, HPGG.  Thus the fish 
desaturases, like all others known, are proteins containing both desaturase and 
cytochrome b5 functions. 
Piscine fatty acid desaturases were first cloned from zebrafish (Danio rerio) and 
rainbow trout using PCR techniques (Hastings et al.  2001; Seiliez et al.  2001). 
Functional characterisation of the zebrafish desaturase by heterologous expression in the 
yeast Saccharomyces cerevisiae showed the enzyme to have both ∆6 and ∆5 desaturase 
activity.  In this the zebrafish desaturase is unique, possessing the only bifunctional 
desaturase involved in HUFA synthesis so far isolated, not only in fish, but in vertebrates 
in general. Furthermore, this desaturase is the only PUFA desaturase represented in the 
zebrafish genome. The zebrafish desaturase also shows a low level of activity towards 
C24 fatty acid substrates suggesting that it also has ∆6* activity (see Fig. 2). In contrast, 
desaturase cDNAs from other freshwater fish, including rainbow trout and common carp 
(Cyprinus carpio) encode unifunctional ∆6 desaturases (Zheng et al.  2004a). However, 
separate cDNAs for ∆6 and ∆5 desaturases have been cloned from Atlantic salmon 
(Hastings et al.  2004; Zheng et al.  2005a), indicating the presence of multiple desaturase 
genes in at least some fish. To date, only ∆6 desaturase cDNAs have been cloned from 
marine fish, including gilthead sea bream, turbot (Psetta maximus) and cod (Gadus 
morhua) (Seiliez et al.  2003; Zheng et al.  2004a; Tocher et al.  2006). All fish 
desaturases are more active towards the n-3 fatty acid substrate than the equivalent n-6 
substrate (Table 1). The Atlantic salmon ∆5 and ∆6 cDNAs are very similar, sharing 
greater than 95% nucleic acid identity, indicating the presence of a recently duplicated 
locus, probably as the result of the recent salmonid tetraploidisation (Allendorf and 
Thorgaard, 1984). The full genomic sequence has only been reported for the Atlantic 
salmon ∆6 desaturase with 13 exons spanning 7965 bp of genomic DNA (Zheng et al.  
2005a). 
The presence of two separate genes for ∆5 and ∆6 desaturase in Atlantic salmon is 
consistent with the biochemical evidence for the production of DHA from 18:3n-3 in this 
species. Similarly, the presence of a bifunctional ∆5/∆6 desaturase in the zebrafish 
genome also suggests that this species can produce DHA from 18:3n-3. The apparent 
inability of sea bream to produce DHA from 18:3 may be explained by the presence of 
only a single unifunctional ∆6 desaturase gene in this species. Thus the inability of some 
species to produce DHA might be explained by the lack of a gene encoding ∆5 activity, a 
deficiency which has no significant consequence in the HUFA-rich marine ecosystem. In  
 
 10
  
 
 Table 1. Functional characterisation of fish fatty acyl desaturase cDNAs
n-3 n-6 n-3 n-6 n-3 n-6 n-3 n-6 n-3 n-6 n-3 n-6 n-3 n-6 n-3 n-6
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bstrates are: ∆6, 18:3n-3 and 18:2n-6; ∆5, 20:4n-3 and 20:3n-6; ∆4, 22:5n-3 and 22:4n-6; ∆6*, 
:5n-3 and 24:4n-6; nd, not detected. 24
contrast, the bifunctional zebrafish gene and multiple subfunctionalized salmon genes 
have enabled these species, which spend all or a significant part of their lifecycles in 
relatively nutrient-poor riverine environments, to produce essential HUFA. These 
conclusions are supported by searches of sequenced fish genomes and phylogenetic 
sequence analysis which, in agreement with classical phylogeny (Nelson, 2006), group 
the above fish desaturases in three distinct clusters. The first includes the common carp 
and zebrafish sequences (Ostariophysi), the second the rainbow trout and Atlantic salmon 
sequences (Salmoniformes), and the third the tilapia (Oreochromis nilotica), sea bream, 
turbot, stickleback (Gasterosteus aculeatus) and medaka (Oryzias latipes) sequences 
(Acanthopterygia) with the cod (Paracanthopterygii) branching from the Acanthopterygia 
line (Fig.3A). Within the three sequenced Acanthopterygii genomes, the medaka possess 
a single HUFA desaturase, the stickleback two very closely related genes and searches of 
the pufferfish (both Tetraodon nigroviridis and Takafugu rubripes;  Acanthopterygii) 
genomes fail to identify any ∆5/∆6 homologues (Fig3A).  
These considerations have clear implications for the formulation and suitability of 
aquaculture feeds containing HUFA-deficient alternatives to FO, and current research is 
aimed at determining the distribution of ∆5 and ∆6 desaturase genes across phyla and in 
understanding the regulation of their expression. 
 
Fatty acyl elongases 
 
Very long chain fatty acyl elongase (ELOVL; Elongation of Very Long chain 
fatty acids) genes, like the fatty acyl ∆5 and ∆6 desaturases, are endoplasmic reticulum 
bound proteins and several distinct elongases have been characterized each with activity 
toward different fatty acid substrates (Jakobsson et al.  2006). ELOVLs condense long 
chain acyl-CoA with malonyl-CoA, thus acting as the substrate-specific components of a 
multienzyme pathway, which also includes ketoreductase, dehydratase and enolase and 
requires NADPH. Thus ELOVL belongs to a multicomponent enzyme system of the 
endoplasmic reticulum analogous to the single component, multi-activity cytosolic fatty 
acid synthase of vertebrates (Jakobsson et al.  2006). In mammals, these genes are now 
termed ELOVL1 to 7 to indicate different substrate specificities and of these at least 
ELOVL2 and ELOVL5 have been shown to participate in HUFA biosynthesis (Leonard 
et al.  2000; Leonard et al.  2002; Jakobsson et al.  2006). 
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Figure 3. Molecular phylogeny of fish and human highly unsaturated fatty acyl desaturases and 
elongases. Panel A: Phylogeny of vertebrate desaturases. Panel B: Phylogeny of vertebrate elongases. 
Desaturase and elongase sequences were obtained from the NCBI/EMBL databases or were derived from 
genomic sequence information by searching (TBLASTN) with zebrafish ∆5/∆6 cDNA sequence. All 
sequences were aligned and neighbour joining trees derived and bootstrapped using ClustalX. Resulting 
unrooted trees were plotted with NJplot. Numbers at nodes indicate the percentage frequency with which 
the tree topology was returned after bootstrapping the multiple alignment data through 1000 iterations. 
NCBI/EMBL protein sequence accession numbers are shown in normal text. ENSEMBL 
(www.ensembl.org) gene identification numbers are shown in italics for protein sequences derived from 
sequenced fish genomes. The accession number for an assembly of various salmon EST sequences from 
www.tigr.org is double underlined. 
 
ELOVL cDNAs of the HUFA biosynthetic pathway have been cloned from a 
number of fish: the freshwater species zebrafish, common carp and tilapia, the salmonids, 
Atlantic salmon and rainbow trout, and the marine species cod, turbot and sea bream 
(Hastings et al.  2004; Agaba et al.  2004; Agaba et al.  2005). These cDNAs encode 
putative open reading frames (ORFs) of 288-294 amino acids that are highly conserved 
among the fish. The predicted elongase polypeptides share characteristic features of 
microsomal ELOVLs, including a single histidine box redox centre motif, a canonical ER 
retention signal (carboxyl-terminal dilysine targeting signal) and multiple transmembrane 
regions. (Meyer et al.  2004). Phylogenetic analysis comparing all the putative ELOVL 
sequences identified from fish, along with a range of ELOVLs from mammals (Fig 3B), 
group the fish elongase cDNAs into a closely related cluster with greatest similarity to 
mammalian ELOVL5.  Interestingly all of the fish ELOVLs tested by heterologous 
expression in yeast exhibit the ability to lengthen n−3 and n−6 PUFA and 
monounsaturated substrates with chain lengths from C18 to C22 (Table 2). ELOVL5, the 
mammalian subtype most similar to all characterized piscine elongases, is predominantly 
involved in the elongation of C18 and C20 PUFA (Leonard et al.  2000), whilst 
mammalian ELOVL2 has greatest activity in the elongation of C20 and C22 (Leonard et 
al.  2002). Notably the zebrafish genome and the Atlantic salmon EST database 
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(www.tigr.org) both contain a second PUFA elongase gene which is clearly related to 
ELOVL2 (Fig 3B.). The substrate specificities of these gene products have not yet been 
tested. Although the analysis of fish ELOVL genes is not yet exhaustive, it is clear that 
the pufferfish, stickleback and medaka and thus probably all other Acanthopterygii do not 
possess ELOVL2 homologues and it is likely that the characterized elongase cDNAs of 
sea bream and turbot are the sole representatives of a PUFA ELOVL gene in these 
species. Thus the varying competences of different fish to biosynthesize HUFA would 
not only depend on their genome complement of desaturase genes but also elongases. 
 
 
 
 
 Table 2. Functional characterisation of fish fatty acyl elongase cDNAs
n-3 n-6 n-3 n-6 n-3 n-6 n-3 n-6 n-3 n-6 n-3 n-6 n-3 n-6
 C
 
 
 
 
18-20 85.4 70.7 87.5 78.3 82.6 71.2 71.8 42.1 49.0 22.8 85.9 84.3 7.4 15.7
20-22 49.4 25.6 48.1 40.8 86.6 61.8 38.9 22.6 39.3 21.3 66.8 43.9 0.8 1.5
22-24 4.9 0.5 2.8 0.9 1.0 tr 0.7 0.3 0.6 0.6 4.7 0.8 nd nd
Results are presented as percentage of substrate fatty acid converted to elongated product. Fatty acid 
substrates are: C18-20, 18:4n-3 and 18:3n-6; C20-22, 20:5n-3 and 20:4n-6; C22-24, 22:5n-3 and 
22:4n-6; nd, not detected; tr, trace (<0.05%). 
Turbot Co
C
C
dZebrafish Catfish Tilapia Salmon Sea bream 
Tissue Distributions and Nutritional Regulation 
 
Both fatty acyl ∆5 and ∆6 desaturase and elongase are most highly expressed in 
intestine, followed by liver and brain, with much lower levels in other tissues (Zheng et 
al.  2005a). Similarly, ∆6 desaturase expression in rainbow trout is high in liver, intestine 
and brain and low in kidney, heart and white muscle (Seiliez et al.  2001). In cod, ∆6 
desaturase and PUFA elongase genes are most highly expressed in brain with high levels 
also in liver kidney and intestine (Tocher et al.  2006). In sea bream, elongase expression 
is highest in liver and intestine, with lower levels in brain and gills. Sea bream desaturase 
expression, like Atlantic salmon and cod, is expressed to high level in liver and brain, but 
in contrast to Atlantic salmon and cod is relatively low in intestine (Diez et al.  2007).  
Genes of the HUFA biosynthetic pathway are also regulated in response to 
substituion of FO by VO. The expression of ∆5 desturase and elongase genes is 
positively and negatively correlated with dietary 18:3n-3 and n-3 HUFA content, 
respectively when Atlantic salmon are fed a linseed oil (high 18:3n-3) based diet for 20 
weeks. After 40 weeks feeding the activity of the HUFA biosynthetic pathway, is 
positively and significantly correlated with dietary linseed oil. Similarly, the ∆5 
desaturase gene is up-regulated in Atlantic salmon fed 75% rapeseed oil compared to fish 
fed FO (Jordal et al.  2005).  At various points during the entire two year production 
cycle in Atlantic salmon fed diets containing either 100% FO or diets where 75% and 
100% of FO was replaced by a VO blend (Zheng et al.  2005b), expression of ∆6 
desaturase mRNA is consistently highest around the point of seawater transfer and lowest 
during the seawater phase. In addition, the expression of both ∆6 and ∆5 desaturase 
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mRNAs is generally higher in fish fed the VO-substituted diets compared to fish fed FO, 
particularly in the seawater phase. These results are consistent with HUFA biosynthesis, 
which varies during the growth cycle with peak activity around seawater transfer and 
subsequent low activities in seawater, and is invariably higher in fish fed the VO blends 
compared to fish fed FO.  The expression of PUFA elongase mRNA is not affected by 
VO inclusion in FO diets. These studies show that both nutritional and environmental 
modulation of HUFA biosynthesis in Atlantic salmon involves regulation of fatty acid 
desaturase gene expression, with desaturase gene expression being higher during the 
transition from freshwater to seawater and when fed with diets containing reduced 
HUFA.  
The expression of the ∆6 desaturase gene in the marine sea bream is apparently 
increased several-fold in liver of fish fed rapeseed, linseed or soybean oil as determined 
by RNase protection (M. J Leaver, G. Krey, unpublished). Similar to sea bream, 
expression of the ∆6 desaturase gene in sea bass liver tends to increase in diets  
containing rapeseed oil, olive oil and, especially, linseed oil and is significantly up-
regulated in liver of fish fed a VO blend. 
In contrast, the expression of freshwater rainbow trout ∆6 desaturase mRNA in 
liver is not significantly affected by dietary VOs, including linseed oil, rapeseed oil, olive 
oil, and a VO blend (Seiliez et al.  2003). Taken together these results suggest that marine 
fish or salmonids in the seawater phase are capable of up-regulating HUFA biosynthetic 
genes and their corresponding activities in response to reductions of HUFA in the diet. 
The extent to which such increases can compensate for the reduction in dietary HUFA in 
VO replacement of FO is as yet unquantified but may vary substantially between Atlantic 
salmon and marine species such as sea bream and sea bass. 
 
TRANSPORT OF FATTY ACIDS 
 
Fatty acids are transported between tissues largely as triglycerides and 
phospholipids incorporated into the lipoproteins of the plasma. Specific mechanisms exist 
in tissue for the uptake and excretion of particular lipoproteins and whilst these have not 
been extensively studied in fish, the activity of lipoprotein lipase (see previous section) is 
an important control point, as are the actions of cellular transport proteins. 
 
Cellular uptake of fatty acids 
 
 In vitro studies with Atlantic salmon hepatocytes also indicate that long-chain n-3 
PUFA may stimulate total β-oxidation through increased uptake of fatty acids into the 
cells rather than stimulating the actual β-oxidation system (Torstensen and Stubhaug, 
2004).  
Unesterified fatty acids can either be transported into cells through a simple 
diffusion mechanism regulated mainly by lipid physical chemistry (Hamilton, 1998), or 
by a protein mediated transport of fatty acids across the cell membrane. The latter 
mechanism involves a membrane-bound fatty acid transport protein (FATP), which has 
been identified in several tissues in rodents and mammals (Frohnert and Bernlohr, 2000). 
FATP cloned from mouse are reported to have very long chain acyl-CoA synthetase 
activity suggesting a fatty acid uptake via esterification coupled influx (Herrmann et al.  
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2001). Studies of FATP in fish are scarce, however one study in rainbow trout show that 
fatty acid uptake is carrier-mediated in both red- and white muscle (Richards et al.  
2004). It has recently been suggested that it is the metabolic demand for fatty acids that is 
the driving force for fatty acid uptake,  through conversion of fatty acids to acyl-CoA, by 
the action of acyl-CoA synthetases and the regulation of the membrane bound transport 
proteins (Mashek and Coleman, 2006). The mitochondrial acyl-CoA synthetase has been 
studied in Antarctic notothenioid fish, reporting substrate specificity for unsaturated fatty 
acids over 16:0 and 22:6n-3 (Grove and Sidell, 2004), however molecular studies have 
not been done on fish acyl-CoA-synthetases. 
 
Intracellular Fatty Acid Binding Proteins 
 
Cytosolic fatty acid binding protein (FABP) may act as an acceptor for fatty acids 
that have been transported across the membrane. The FABP are low molecular mass (14-
16 kDa) soluble proteins that non-covalently bind long chain fatty acids and other small 
organic hydrophobic molecules. They belong to a multigene family of intracellular lipid-
binding proteins (iLBP) that also includes cellular retinol and retinoic acid binding 
proteins. Specific FABP have been found in various cell and tissue types (Matarese et al.  
1989; Hertzel and Bernlohr, 2000) and it is generally considered that the FABPs fullfil 
specialised roles in cells where they are expressed, but definitive proof has not been 
forthcoming.  For example, heart FABP is considered to shuttle fatty acids from the 
plasma membrane to mitochondria for β-oxidation while the adipocyte FABP is 
considered to facilitate efflux of lipolytically-derived fatty acids  (Londraville and Sidell, 
1996; Coe and Bernlohr, 1998). In rat heart and muscle there is a clear correlation 
between fatty acid oxidation and cytosolic FABP content (Veerkamp and Vanmoerkerk, 
1993; Furuhashi et al.  2002). 
In sunfish the expression of heart FABP is increased relative to control after 
injections of murine leptin (Londraville and Duvall, 2002), suggesting a central role of 
FABP in lipid metabolism, especially in fish fed high lipid diets. Furthermore 
intracellular FABP concentrations are reported to increase in response to cold acclimation 
(Londraville and Sidell, 1996), which is correlated with increased β-oxidation.  
In Atlantic salmon the levels of FABP3 (isofrom 3) mRNA are approximately 100 
fold higher in red muscle compared to white muscle, which may be correlated with 
higher β-oxidation capacity and fatty acid metabolism activity in red muscle (Jordal et al.  
2006). In addition, protein levels of FABP3 in red and white muscle increase after 
replacing dietary FO with rapeseed oil (Jordal et al.  2006), which again correlates with 
increased β-oxidation capacity (Stubhaug et al.  2005). However, FABP3 protein levels in 
Atlantic salmon muscle do not correlate with FABP3 mRNA levels during a long-term 
feeding study (Jordal et al.  2006). 
  
ROLE OF FATTY ACIDS IN GENE REGULATION  
 
Fatty acids and their derivatives are known to directly regulate the activities of a 
variety of transcription factors whose functions are in the control of genes responsible for 
fatty acid, cholesterol and carbohydrate metabolism (Jump, 2004). These transcription 
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factors include sterol regulatory element binding proteins (SREBP), hepatic nuclear 
factor4 (HNF4), liver X receptor (LXR), farnisoid X receptor (FXR) and the peroxisome 
proliferators-activated receptors (PPARs). In fish, with the exception of PPARs, these 
proteins and their genes have not been much studied. However the availability of 
genomic sequences from fish at least will make it possible to identify homologues of 
these important genes in fish. 
 
Peroxisome Proliferator-Activated Receptors. 
 
Since their initial discovery as transcription factors which were activated by a 
variety of chemical and pharmacological compounds known to induce peroxisome 
proliferation in rodents (Issemann and Green, 1990), PPARs have been intensively 
studied in humans and rodents and have been the subject of several detailed reviews (eg 
(Desvergne et al.  2004; Hihi et al.  2002). PPARs are ligand-activated nuclear hormone 
receptors which act as heterodimers with retinoid X receptors (RXR). PPAR/RXR 
heterodimers bind to DNA sequences consisting of a consensus direct repeat of 
AGGTCA separated by 1 base pair (DR1 sequence). The PPAR/RXR heterodimer is a 
“permissive” complex in that it can be activated either by PPAR ligands or by RXR 
ligands. In mammals three genes encode PPARs; PPARα, PPARβ (or δ) and PPARγ. 
These genes have distinct tissue expression profiles, which along with the tissue specific 
expression of corepressor and coactivator proteins, and differences in ligand selectivity, 
determine their roles in regulating genes involved in fatty acid homeostasis (Desvergne et 
al.  2006). The endogenous ligands of PPARs have not yet been unambiguously 
identified. All mammalian PPARs bind and are activated by unsaturated fatty acids, 
although a variety of  oxidised derivatives of fatty acids, for example eicosanoids, have 
higher affinity and are more subtype specific. This has led to the view that PPARs are 
general fatty acid sensors, responding to increased cellular fatty acid levels or their 
metabolites which arise as a result of changes in nutritional status and energy metabolism 
(Michalik et al.  2006). Due to their important functions in fatty acid metabolism, PPARs 
have also been the subject of several studies in fish including Atlantic salmon and sea 
bream. 
 
PPARα 
 
In mammals a single gene for PPARα encodes a transcription factor which is 
predominantly expressed in highly oxidative tissues such as liver and heart (Escher et al.  
2001). Activating ligands for this receptor include fatty acids and some of their 
eicosanoid metabolites as well a variety of synthetic compounds (Desvergne and Wahli, 
1999). Mice lacking PPARα are unable to up-regulate hepatic β-oxidation in response to 
starvation develop fatty liver and also show cardiac metabolic defects (Leone et al.  
1999). A number of studies (reviewed in Mandard et al.  2004) have demonstrated that 
PPARα regulates genes involved in fatty acid oxidation, amino acid metabolism and 
glucose homeostasis. Thus, the ability of PPARα to increase fatty acid β-oxidation is of 
considerable interest in aquaculture where fish are fed high fat diets in an effort to 
maximise the energy that can be supplied by dietary lipid, and so “spare” dietary protein 
for the synthesis of new tissue/flesh (Sargent and Tacon, 1999). PPARα subtype cDNAs 
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have been characterized from sea bream, sea bass and plaice (Pleuronectes platessa) 
(Boukouvala et al.  2004; Leaver et al.  2005). These proteins bear high identity to 
mammalian PPARα and for reasons discussed below have been termed PPARα2. 
Cellular transfection experiments have established that these fish PPARα2 subtypes are 
activated by unsaturated fatty acids, and also by the mammalian PPARα-specific ligand 
Wy-14643. Furthermore, in sea bream and plaice, PPARα2 mRNA is most highly 
expressed in liver and heart indicating that PPARα2 is structurally and functionally 
homologous to mammalian PPARα. However searches of the genome data for pufferfish 
and zebrafish indicate that a further gene with a close phylogenetic relationship to 
PPARα is present in these fish genomes (Maglich et al.  2003; Leaver et al.  2005). The 
functional characteristics of this subtype are presently unknown, but interestingly a 
PPARα cDNA from Atlantic salmon (M. J. Leaver, unpublished) is clearly a homologue 
of the second uncharacterized gene from pufferfish, stickleback and medaka (Fig 4.) and 
has been termed PPARα1. At present it is not known whether Atlantic salmon possess 
both PPARα subtypes but, from the phylogenetic evidence, it seems likely that they do. 
The presence of PPARα1 has also been recently confirmed in sea bream and sea bass (M. 
J. Leaver, G. Krey, unpublished). Since Ostariophysi (zebrafish), various Acanthopterygii 
(sea bream, sea bass, plaice, pufferfish, stickleback and medaka) and probably salmonids 
all possess two conserved PPARα subtypes it is probable that all of the major bony fish 
clades are similarly endowed (Fig 4). This would indicate that PPARα1 has a specific 
function in fish distinct from that of PPARα2 and by extension mammalian PPARα. 
However, the functional characterization of this isoform is essential in order to fully 
address this hypothesis. 
Compounds which activate PPARα and increase β-oxidation in mammals have 
been tested in fish. The activity of ACO in Atlantic salmon hepatocytes is only mildly 
increased after fibrate treatment (Ruyter et al.  1997). Similarly the expression of ACO in 
Atlantic salmon liver and muscle is not affected by dietary tetradecylthioacetic acid 
(TTA; Kleveland et al.  2006a) which is in contrast to findings in rats (Froyland et al.  
1996), where these compounds dramatically increase ACO via activation of PPARα. 
However, in Atlantic salmon, hepatic mitochondrial β-oxidation is significantly increased 
by dietary TTA whereas ACO activity is unaffected (Moya-Falcon et al.  2006). In 
contrast, rainbow trout treated with fenofibrate (a potent mammalian PPARα agonist) 
show increased hepatic ACO activity and peroxisomal β-oxidation, whereas 
mitochondrial β-oxidation and CPT1 activity remain unchanged (Du et al.  2004). Thus, 
it is unclear whether these compounds have significant effects in salmonids. It should be 
noted that, although they have PPARα-mediated effects in rodents, these compounds 
have not yet been tested as direct activators of piscine PPARs. Nevertheless, in sea bream 
and plaice conjugated linoleic acid (CLA) is one of the most effective fatty acid 
activators of PPARα2 in cellular transfection assays. Feeding of CLA to Atlantic salmon 
increases hepatic β-oxidation (Leaver et al.  2006) and CLA feeding increases ACO 
activity in sea bream. (Diez et al.  2007). Finally, it is of interest that the expression of 
PPARα2 in the liver of sea bream appears to be dependent on the nutritional status of the 
fish, in a manner highly similar to that of mammalian PPARα. Thus, PPARα2 liver 
mRNA expression is increased by fasting and decreased by feeding (Leaver et al.  2005). 
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This effect appears to be liver-specific, as it has not been observed in the muscle, 
intestine, adipose, or heart tissues of sea bream (Diez et al.  2007).  
 
PPARβ 
 
Mammals have a single gene encoding PPARβ and various studies suggest that it 
has a role in global control of lipid homeostasis. It is moderately activated by a range of 
unsaturated fatty acids (Forman et al.  1997) and has a broad tissue expression profile 
(Escher et al.  2001). PPARβ-deficient mice show reduced adipose stores (Peters et al.  
2000) and treatment with synthetic ligands has demonstrated that PPARβ directly 
controls lipid utilisation through up-regulation of genes involved in β-oxidation and 
energy uncoupling in various tissues (Dressel et al.  2003; Tachibana et al.  2005). In 
addition to functioning as a regulator of energy metabolism PPARβ has also been shown 
to have significant roles in the control of cellular proliferation and differentiation 
(Burdick et al.  2006). PCR-amplified products of partial nuclear hormone receptor genes 
from zebrafish and Atlantic salmon suggest that more than one gene for PPARβ may be 
present in fish (Robinson-Rechavi et al.  2001) and examination of the zebrafish genome 
database indicated that there are two PPARβ genes in this Cypriniform (Leaver et al.  
2005). However the subsequent generation and characterization of full length PPARβ 
cDNAs from the Acanthopterygii, sea bream and plaice, indicate that these species 
contain a single PPARβ gene. Furthermore, information from the pufferfish, stickleback 
and medaka (also Acanthopterygia) genome sequencing projects show that these fish also 
possess a single PPARβ gene (Fig 4). In plaice, sea bream and sea bass the single PPARβ 
gene shares many of the characteristics of its mammalian counterpart, having a broad 
tissue expression profile and being activated by unsaturated fatty acids (Leaver et al.  
2005; Boukouvala et al.  2004).  
In contrast to both cyprinids and Acanthopterygia, genomic screening of Atlantic 
salmon revealed the presence of four PPARβ genes. (Leaver et al.  2007). These genes 
phylogenetically cluster as two families, termed ssPPARβ1 and ssPPARβ2, each 
containing two very similar genes (Fig. 4). The explanation for these differences in gene 
number in different fish is probably provided by the hypothesis that early in bony fish 
evolution a duplication of the ancestral genome took place (Meyer and Van De Peer, 
2005). As different lineages of fish diverged these genes were either retained (e.g. the 
two PPARβ subtypes in zebrafish) or lost (e.g. the single PPARβ in pufferfish and all 
other Acanthopterygii so far studied) as has been demonstrated by genome comparisons 
(Woods et al.  2005). Atlantic salmon and other salmonids have undergone a further more 
recent genome duplication (Allendorf and Thorgaard, 1984) and this has resulted in the 
further duplication of two PPARβ genes, derived from the early fish genome duplication. 
Recent functional studies of the Atlantic salmon PPARβ genes shows that two of these 
subtypes have diverged functionally. Thus, ssPPARβ1A, bears all of the characteristics of 
other PPARβ subtypes from mammals and fish, being activated by unsaturated fatty acids 
and being strongly activated by the mammalian PPARβ-specific ligand GW501506. In 
contrast the other Atlantic salmon PPARβ subtype, ssPPARβ2A, is not activated by 
either fatty acids or synthetic ligands and moreover exerts a strong repression on the 
transcriptional activity of ssPPARβ1A. Whether ssPPARβ2A is activated by another as 
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yet undiscovered ligand and whether it exerts transcriptional repression on other PPARs 
or nuclear hormone receptors in general is not yet known. ssPPARβ1A and β2A are also 
differentially expressed, with β1A predominating in liver and β2A in gill (Leaver et al.  
2007), which, given the potential for transcriptional repression and the possibility of 
nutritional regulation as observed in sea bream, would lead to considerably more 
complexity in PPAR signaling in salmonids than in the Acanthopterygii or in mammals. 
 
PPARγ 
 
PPARγ is encoded by a single gene in mammals which, through alternative 
splicing, gives rise to two proteins, PPARγ1 and PPARγ2, with distinct N-terminal 
sequence (Tontonoz et al.  1994). PPARγ2 is highly expressed in adipose tissue whereas 
PPARγ1 is expressed to a high level in gut and at a much lower level in a variety of other 
tissues (Escher et al.  2001). Mammalian PPARγ is essential for fat accumulation 
particularly in adipocytes, but also in lipid-accumulating macrophages (Rosen et al.  
1999; Fajas et al.  2001). 
PPARγ was the first PPAR subype to be identified in fish, with cDNAs characterised 
from Atlantic salmon and plaice  (Ruyter et al.  1997; Leaver et al.  1998). Subsequently 
the availability of genome information for zebrafish, stickleback, medaka and pufferfish 
has shown that, as in mammals, these fish possess a single PPARγ gene and studies on 
sea bream, sea bass and plaice also indicate the presence of a single gene (Fig 4; 
(Maglich et al.  2003; Boukouvala et al.  2004; Leaver et al.  2005). There are no 
indications yet of alternatively spliced products and thus alternative PPARγ proteins in 
fish. So far transcriptional activity has not been demonstrated for any fish PPARγ. Both 
fatty acids and mammalian PPARγ-specific ligands fail to activate sea bream or plaice 
PPARγ (Leaver et al.  2005) and similarly Atlantic salmon PPARγ is unresponsive to 
typical mammalian PPARγ agonists (Leaver et al., unpublished). Although fish PPARγ is 
clearly a homologue of mammalian PPARγ, all piscine PPARγ proteins so far identified 
have a critical amino acid substitution, where a tyrosine residue conserved in all 
mammalian PPARs and essential for binding the carboxylic head group of fatty acids and 
synthetic ligands, is substituted for a methonine. This is suggested to abolish the ability of 
fatty acids and synthetic ligands to activate piscine PPARγ (Leaver et al.  2005; Maglich 
et al.  2003). Thus it is likely that piscine PPARγ is activated by as yet unidentified 
compounds, although given the overall similarity in structure to mammalian PPARγ, 
these unidentified compounds are likely to be related to fatty acids. Differences between 
mammalian and piscine PPARγ are also evident from tissue expression profiles. PPARγ 
is expressed at a high level relative to other PPARs and in comparison to mammalian 
PPARγ in a wide range of sea bream and plaice tissues (Leaver et al.  2005). 
Furthermore, the expression of sea bream hepatic PPARγ mRNA levels increase upon 
feeding, whilst in adipose tissue they remain unchanged. In mammals feeding induces an 
increase in adipose PPARγ expression. Taken together the studies on piscine PPARγ 
suggest that, although a sequence homologue of mammalian PPARγ, it has diverged 
functionally. Given the critical role of mammalian PPARγ in fat accumulation, it is  
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Figure 4. Molecular phylogeny of the ligand binding domains of PPARs. 
PPAR sequences were obtained from the NCBI/EMBL databases or were derived from genomic sequence 
information by searching (TBLASTN) with human PPARβ protein sequence. All sequences were aligned 
and neighbour joining trees derived and bootstrapped using ClustalX. Resulting unrooted trees were plotted 
with NJplot. The tree was rooted to the most similar nuclear receptor from the ascidian Ciona intestinalis. 
Numbers at nodes indicate the percentage frequency with which the tree topology was returned after 
bootstrapping the multiple alignment data through 1000 iterations. NCBI/EMBL protein sequence 
accession numbers are shown in normal text. ENSEMBL (www.ensembl.org) gene identification numbers 
are shown in italics for protein sequences derived from sequenced fish genomes. The accession number for 
an assembly of various salmon EST sequences from www.tigr.org is double underlined. 
 
pertinent to ask the question whether the process of fat accumulation in fish might differ 
substantially from that in mammals. The identification of agonists for piscine PPARγ is a 
necessary step for further studies. 
 
Other Fatty Acid-Activated Transcription Factors 
 
In addition to PPARs a number of other transcription factors are activated by fatty 
acids (Clarke, 2004). Furthermore there are complex interactions among nuclear hormone 
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receptors which are activated by cholesterol metabolites and bile acids (eg LXR and 
FXR) and those activated by fatty acids and their metabolites, such as PPARs (Desvergne 
et al.  2006). Other transcription factors directly activated by fatty acids include the Sterol 
Regulatory Element Binding Proteins (SREBPs) which are encoded by two genes, 
SREBP1 and SREBP2, in humans and other mammals. SREBP2 responds to membrane 
cholesterol levels and is activated when cellular cholesterol is low (Mcpherson and 
Gauthier, 2004). Its predominant function is the regulation of genes of the cholesterol 
biosynthesis pathway (Caballero et al.  2002; Maxwell et al.  2003). The SREBP1 gene 
gives rise to two proteins, SREBP1a and SREBP1c, by alternative splicing. SREBP1c is 
also responsive to reduced cholesterol and predominantly up-regulates the genes of the 
HUFA biosynthetic pathway, including fatty acyl ∆5 and ∆6 deaturases and fatty acyl 
elongases (Caballero et al.  2002). Increased cellular PUFA levels decrease the activity of 
SREBP1c by mechanisms which are not yet understood (Chen et al.  2004; Mcpherson 
and Gauthier, 2004). There are no studies yet of SREBPs in fish despite their importance 
in the regulation of HUFA biosynthesis. 
Hepatic nuclear factor 4 (HNF4) proteins are transcription factors belonging to 
the nuclear receptor hormone superfamily. They are encoded by two distinct genes in 
mammals, termed HNF4α and HNF4γ in humans, with a broad and overlapping tissue 
distribution (Drewes et al.  1996). HNF4 functions as a homodimer and binds to a DR1 
repeat (Jiang et al.  1995) which shares a minimal consensus sequence with the elements 
bound by PPAR/RXR heterodimers, suggesting at least some degree of transcriptional 
cross-talk. Saturated and monounsaturated fatty acids between 14 and 18 carbons in 
length are bound tightly to both HNF4α and HNF4γ when isolated from heterologous 
expression systems (Wisely et al.  2002). This is likely to occur in vivo where the 
presence of a permanently bound fatty acid is suggested to engender HNF4 with high 
constitutive activity (Dhe-Paganon et al.  2002). HNF4α regulates a large and diverse 
array of genes in liver and in pancreas, including genes for fatty acid and glucose 
metabolism. Indeed HNF4α may have a role in controlling up to 50% of the 
transcriptionally active genes in liver (Odom et al.  2004). Analysis of pufferfish 
genomes indicates that these species also possess two genes for HNF4 and these are 
homologous to human HNF4α and HNF4γ (Maglich et al.  2003) and HNF4 regulates a 
major fraction of liver specific genes in zebrafish (Cheng et al.  2006) suggesting similar 
roles to those in mammals. 
 
ENDOCRINE CONTROL OF LIPID METABOLISM 
  
Lipid homeostasis is known to be regulated by a variety of interacting peptide 
hormones in fish.  These hormones act at many different target tissues and may 
participate in protein, carbohydrate and lipid metabolism simultaneously. To cover all 
these aspects and hormones is beyond the scope of this review. Furthermore, it is clear 
that a comprehensive picture of the endocrine control of lipid homeostasis in fish is still 
lacking. Not only have important lipid-regulating hormones only recently been 
characterized in fish, but it is likely that there are important hormones yet to be identified. 
In addition, research during past decades on the endocrine control of lipid metabolism has 
been both sparse and fragmented and there is an obvious need to expand exploration of 
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endocrine-nutritional interactions at the molecular level. The focus here will be on insulin 
and the recently discovered hormones ghrelin and leptin. 
 
Pancreatic hormones 
 
Insulin 
 
Insulin has been identified in numerous fish (Conlon 2001), and often two insulin 
genes are present (Kavsan et al.  1993; Mommsen et al.  2001; Papasani et al.  2006). As 
in mammals, insulin has an anabolic action in fish, enhancing lipid storage by activating 
lipogenesis, and increasing protein synthesis and body growth (Nelson and Sheridan, 
2006). Insulin receptors are present in several tissues, including adipose tissue (Navarro 
et al.  2002). In rainbow trout, insulin acts at several levels to promote lipid storage. 
Insulin affects the activity of the lipid mobilizing enzyme triacylglycerol lipase (TG 
lipase), by altering its state of phosphorylation (Plisetskaya, 1998; Harmon and Sheridan, 
1992a; Harmon et al.  1993) et al.  1993). In addition, insulin stimulates adipose LPL 
activity in rainbow trout (Albalat et al.  2006). In vitro, insulin stimulates hepatic de novo 
lipid synthesis (Cowley and Sheridan, 1993), and inhibits adipocyte and hepatic lipolysis 
(Albalat et al.  2005b; Harmon and Sheridan, 1992a). In sea bream, on the other hand, 
insulin does not affect adipocyte lipolysis in vitro, except in fish fed a plant protein diet 
(Albalat et al.  2005a).  Insulin may also modulate gene transcription as in Atlantic 
salmon hepatocytes where it upregulates mRNA levels of scavenger receptor class B, 
type I, which is important in mammalian lipid homeostasis (Kleveland et al.  2006b). 
Further, in red sea bream, the LPL gene contains a sequence homologous to the 
mammalian insulin responsive element (Oku et al.  2002) and insulin appears to induce 
adipocyte differentiation and increase differentiation-linked expression of the LPL gene 
in red sea bream (Oku et al.  2006). Nutritional status may influence the biological 
activity of insulin and hence link lipid nutrition to metabolism in rainbow trout, as plasma 
insulin levels decrease during fasting and postprandially along with a decreased number 
of insulin receptors in adipose tissue (Planas et al.  2000).  Glucose injections stimulate 
lipolysis in rainbow trout, which is associated with a decrease in plasma insulin levels 
and an increase in TG lipase activity and elevated plasma fatty acid levels (Harmon et al.  
1991; Harmon and Sheridan, 1992b).  
 
Glucagon  
 
Glucagon belongs to the secretin hormone family, which includes a number of 
other hormones having a vast array of metabolic affects. The glucagon gene encodes for 
several peptides that are expressed in different tissues (Nelson and Sheridan, 2006). 
Glucagon is lipolytic and stimulates hepatic TG lipase activity in rainbow trout and coho 
salmon (Harmon and Sheridan, 1992a; Plisetskaya et al.  1989). Glucagon also stimulates 
TG lipase activity in adipocytes in sea bream and rainbow trout (Albalat et al.  2005a; 
Albalat et al.  2005b). However, further studies are needed to understand the molecular 
mechanisms of glugon action in fish. 
 
Ghrelin   
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Ghrelin was identified as a growth hormone (GH) secretogogue in 1999 using the 
“orphan receptor strategy” and the fact that a number of G-protein coupled receptors had 
been found in the genomes of mammals and fish. The receptors were expressed in 
cultured cells and their activation monitored by changes in second messenger systems. 
This functional genomics approach was further used to investigate the physiological 
function of ghrelin and its receptor, called the GH secretogogue receptor or the ghrelin 
receptor (Kojima and Kangawa, 2005). The hormone has now been cloned in several fish, 
including rainbow trout and sea bream (Kaiya et al.  2003; Yeung et al.  2006; Kojima 
and Kangawa, 2005; Kangawa, 2005). In these two species, mature ghrelin ranges from 
20 to 24 amino acids and it has a unique fatty acid modification on the third amino acid, 
common to all species, which is necessary for its biological activity (Kojima and 
Kangawa, 2005). Ghrelin is expressed only in stomach of sea bream, whereas in rainbow 
trout, relatively high expression is also found in brain, hypothalamus and intestine (Kaiya 
et al.  2003; Yeung et al.  2006). The genomic organization of rainbow trout ghrelin 
differs from other fish, and is more similar to the mouse ghrelin gene (Kojima and 
Kangawa, 2005). Functional analysis of the sea bream ghrelin gene indicates that several 
factors in the regulation of ghrelin transcription differ from mammals, e.g. candidate 
transcription factor-binding sites (Yeung et al.  2006). Two cDNA transcripts, primarily 
expressed in the pituitary and central nervous system for a single ghrelin receptor gene 
have also been reported for black sea bream (Chan and Cheng, 2004). Chronic ghrelin 
treatment stimulates food intake and increased liver and muscle fat deposition in tilapia 
and rainbow trout (Riley et al.  2005; Shepherd et al.  2007). However, the effect of 
conspecific ghrelin on salmon or sea bream food intake and lipid metabolism is not yet 
known. Ghrelin clearly has several mechanisms of action to promote lipid storage in 
rodents, e.g. by increasing food intake while decreasing fat utilization (Tschop et al.  
2000), and increasing the transcription of various lipogenic enzymes in white adipose 
tissue (Barazzoni et al.  2005). It also stimulates preadipocyte differentiation and 
upregulates the expression of PPAR-γ2 during this process (Choi et al.  2003). There is 
circumstantial evidence that ghrelin is involved in energy storage in rainbow trout; 
plasma ghrelin levels are positively correlated to condition factor, liver and muscle lipid 
content, and suppressed during long-term fasting (Jönsson et al.  2007). This is opposite 
to results from mammals (Kojima and Kangawa, 2005), indicating that there may be 
species-differences in ghrelin function. Given that ghrelin stimulates GH secretion, and 
that GH is a lipolytic hormone, understanding the interaction between the GH-IGF-I 
system and ghrelin in regulating growth and adiposity represents a challenge. 
Interestingly, the recently discovered hormone obestatin which decreased food intake in 
rats, is derived from the ghrelin gene through post-translational modifications (Zhang et 
al 2005). The sea bream ghrelin gene shows a region with low similarity to mammalian 
obestatin (Yeung et al.  2006), and it remains to be investigated whether this represents 
an orthologue of mammalian obestatin.  
 
Leptin  
 
 Through advances in mammalian research, it is clear that adipose tissue is not 
only a passive fat storage site, but a highly active secretor of numerous peptide hormones 
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and cytokines, which act at various sites to regulate energy homeostasis (Ahima, 2006). 
The most well studied of these is the ob gene product leptin, the discovery of which was a 
scientific breakthrough in the understanding of how body weight is regulated in mammals 
(Zhang et al.  1994). Leptin is a peptide hormone belonging to the class-I helical 
cytokines. It is produced predominantly in adipose tissue, and circulates in proportion to 
body mass in mammals, functioning as a negative feedback signal which regulates fat 
stores. Cytokines are not well conserved between phyla and the identification of fish 
homologues or orthologues of important cytokines has proved difficult, as for fish leptin 
(Huising et al.  2006b). Leptin-like immunoreactivity in fish has been reported, but the 
validity of using heterologous mammalian antibodies in these assays has been questioned 
(Johnson et al.  2000). However, as the gene structure of orthologous cytokines is well 
conserved, the availability of genome sequences for pufferfish and zebrafish enabled the 
search for candidate piscine cytokine genes by concentrating searches in areas of the 
genome flanked by genes which are clearly conserved, at the sequence and positional 
level in mammals. This genomic synteny approach resulted in the identification of leptin 
genes in pufferfish (Takifugu rubripes) and common carp (Kurokawa et al.  2005; 
Huising et al.  2006a). Unlike in mammals, leptin appears to be mostly expressed in the 
liver of these two species. Leptin-like genes for pufferfish, medaka and Atlantic salmon 
were found through further database searches (Kurokawa et al.  2005), and the lepin gene 
for rainbow trout has been added to GeneBank (Accession number AM042713.1). Future 
studies will reveal if there are general species differences in the tissue expression of 
leptin in fish. 
In mammals, leptin acts on the central nervous system, decreasing food intake, 
and activating sympathetic activity to increase energy expenditure through thermogenesis 
and elevated fatty acid oxidation, which results in weight loss. However, due to the recent 
discovery of leptin in fish, physiological studies using homologous hormones are still 
lacking and available data on leptin action in fish are based on the use of mammalian 
leptin. Leptin treatment of salmonids revealed no clear physiological effects (Baker et al.  
2000), but in goldfish, it suppressed food intake (Volkoff et al.  2003; De Pedro et al.  
2006). Chronic leptin treatment decreased appetite as well as liver lipid content in 
goldfish, with concomitant elevation of hepatic and muscle glycogen stores (De Pedro et 
al.  2006). Due to the exceptionally low sequence similarity between fish and mammalian 
leptins, these data must be interpreted with caution and repeated with conspecific fish 
leptin. In common carp, there is a postprandial increase in leptin mRNA expression, but 
no long-term effects of fasting on leptin mRNA expression was observed despite clear 
effects on body weight and metabolism (Huising et al.  2006a). Data indicate that plasma 
leptin levels may be positively correlated with plasma PGE2 levels, but a human leptin 
immoassay kit was used (Richard et al.  2006). Hopefully, conspecific tools will be 
established in the near future, enabling more relevant research on leptin function in fish.   
 
Other hormones  
 
With lipid metabolism being of central importance for energy balance and general 
physiology of fish as in other vertebrates, hormones involved in the regulation of various 
life processes are likely to affect lipid homeostasis, directly or indirectly. These include 
neuropeptides involved in regulation of feed intake and appetite, such as corticotrophin-
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releasing factor (CRF), bombesin, cholecystokinin (CCK), galanin, opiod peptides and 
neuropeptide Y (for review, see De Pedro and Björnsson, 2001). Also, hormones 
regulating appetite, growth and metabolism, in particular, growth hormone (GH), insulin-
like growth factor I (IGF-I) and somatostatin may have indirect effects on lipid 
homeostasis, in addition to the direct lipolytic effects of GH on the liver in salmonids (for 
review see, (Bjornsson, 1997; Bjornsson et al.  2002; Perez-Sanchez et al.  2002). Stress-
related hormones such as catecholamines and corticosteroids affect energy balance 
including lipid stores (for review see (Wendelaar Bonga, 1997). Puberty and sexual 
maturation represents a life stage transition where significant amounts of lipids are 
needed for gonadal maturation, as well as for the physical activity, including migration, 
related to spawning. Thus, not only may reproductive hormones affect lipid stores 
indirectly, but lipid stores have long been hypothesized to be of major importance for 
triggering life stage transitions such as puberty, as well as smoltification of salmonids 
(Shearer and Swanson, 2000; Morgan et al.  2002). The pituitary hormone somatolactin, 
exclusive to fish, has been suggested to have a role in lipid metabolism (Company et al.  
2001 ; De Celis et al.  2004 ; Fukada et al.  2005). 
 
CONCLUSIONS AND PERSPECTIVES 
 
Although there have been numerous studies on piscine lipid metabolism and on 
the expression and function of selected genes involved in lipid homeostasis, the results 
have been at times conflicting. Attention is seldom paid to the metabolic differences 
which exist between fish as well as postprandial effects or to developmental stage. Much 
of the difference among fish is doubtless a result of particular metabolic and life history 
adaptations to varied environments. For example, Atlantic salmon may have adapted to 
relatively nutrient poor riverine environments by subfunctionalization of multiple fatty 
acyl desaturase genes which originally arose as a result of a salmonid tetraploidization 
event.  In contrast, it is likely that the marine sea bream and other marine species have a 
relative deficiency of HUFA biosynthetic machinery that makes these species dependent 
on nutrient rich marine food sources. These types of studies have direct relevance to the 
formulation of optimal diets for the domestication of fish in aquaculture. The availability 
of fish genome sequences are providing critical information to facilitate much of the 
research in this area, and the prospect of a salmonid genome sequence would further 
empower aquaculture researchers. A recent example is the in silico discovery of the fish 
leptin gene using the pufferfish genome and such approaches will prove valuable for 
further identification and characterization of novel fish hormones. In the immediate 
future, the main challenges are to integrate the available genomic data with physiological 
studies on fish and to access powerful genetic manipulation technologies available for the 
model species zebrafish and medaka.  However, given what we already know of the 
diversity of gene numbers and physiological responses in different fish, there is a strong 
argument for choosing model species with care. For example the use of medaka to 
address problems or hypotheses in relating to the nutrition of the marine Acanthoptergii, 
(eg sea bass or sea bream) would be preferable to using the more distantly related 
zebrafish. A major objective will be the integration of data from model species with the 
effects of endocrine hormones, lipid metabolism and life history in commercial or 
environmentally relevant fish and the availability of high density cDNA microarrays for 
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Atlantic salmon and for sea bream will provide platforms for undertaking this research. 
The outcomes of fish nutrigenomic research will not just be of relevance to aquaculture 
but will also enable the identification of differences underlying vertebrate physiologies. 
These outcomes will elucidate species-specific adaptations to environmental conditions, 
and have the potential to inform and stimulate research in many biological disciplines, 
from ecology to human health. 
 
ACKNOWLEDGEMENTS 
 
This review summarizes the results of studies largely funded by the Commission of the European 
Communities.and has been carried out within the project “AQUAFUNC” (EU-SSA-022685) with 
financial support from the Commission of the European Communities. 
 
REFERENCES 
 
Agaba, M., Tocher, D.R., Dickson, C.A., Dick, J.R. and Teale, A.J. Zebrafish cDNA 
encoding multifunctional fatty acid elongase involved in production of 
eicosapentaenoic (20 : 5n-3) and docosahexaenoic (22 : 6n-3) acids.  Marine 
Biotechnology  6, 251-261 (2004) .  
Agaba, M.K., Tocher, D.R., Zheng, X.Z., Dickson, C.A., Dick, J.R. and Teale, A.J. 
Cloning and functional characterisation of polyunsaturated fatty acid elongases of 
marine and freshwater teleost fish.  Comparative Biochemistry and Physiology B-
Biochemistry & Molecular Biology  142, 342-352 (2005)  . 
Ahima, R.S. Adipose tissue as an endocrine organ.  Obesity  14, 242-249 (2006). 
Albalat, A., Gomez-Requeni, P., Rojas, P., Medale, F., Kaushik, S., Vianen, G.J., Van 
Den Thillart, G., Gutierrez, J., Perez-Sanchez, J. and Navarro, I. Nutritional and 
hormonal control of lipolysis in isolated gilthead seabream (Sparus aurata) 
adipocytes.  American Journal of Physiology-Regulatory Integrative and Comparative 
Physiology  289, R259-R265 (2005a). 
Albalat, A., Gutierrez, J. and Navarro, I. Regulation of lipolysis in isolated adipocytes of 
rainbow trout (Oncorhynchus mykiss): the role of insulin and glucagon.  Comparative 
Biochemistry and Physiology a-Molecular & Integrative Physiology  142, 347-354 
(2005b). 
Albalat, A., Sanchez-Gurmaches, J., Gutierrez, J. and Navarro, I. Regulation of 
lipoprotein lipase activity in rainbow trout (Oncorhynchus mykiss) tissues.  General 
and Comparative Endocrinology  146, 226-235 (2006). 
Allendorf, F.W. and Thorgaard, G.H. Tetraploidy and the evolution of salmonid fishes.  
In Evolutionary genetics of salmonid fishes. Eds. Turner, B.J., New York, Plenum 
Press pp. 1-53 (1984). 
Alvarez, M.J., Diez, A., Lopez-Bote, C., Gallego, M. and Bautista, J.M. Short-term 
modulation of lipogenesis by macronutrients in rainbow trout (Oncorhynchus mykiss) 
hepatocytes.  British Journal of Nutrition  84, 619-628 (2000). 
Baker, D.M., Larsen, D.A., Swanson, P. and Dickhoff, W.W. Long-term peripheral 
treatment of immature coho salmon (Oncorhynchus kisutch) with human leptin has no 
clear physiologic effect.  General and Comparative Endocrinology  118, 134-138 
(2000). 
 26
Barazzoni, R., Bosutti, A., Stebel, M., Cattin, M.R., Roder, E., Visintin, L., Cattin, L., 
Biolo, G., Zanetti, M. and Guarnieri, G. Ghrelin regulates mitochondrial-lipid 
metabolism gene expression and tissue fat distribution in liver and skeletal muscle.  
American Journal of Physiology-Endocrinology and Metabolism  288, E228-E235 
(2005).  
Bezard, J., Blond, J.P., Bernard, A. and Clouet, P. The metabolism and availability of 
essential fatty-acids in animal and human tissues.  Reproduction Nutrition 
Development  34, 539-568 (1994). 
Bjornsson, B.T. The biology of salmon growth hormone: from daylight to dominance.  
Fish Physiology and Biochemistry  17, 9-24 (1997). 
Bjornsson, B.T., Johansson, V., Benedet, S., Einarsdottir, I.E., Hildahl, J., Agustsson, T. 
and Jonsson, E. Growth hormone endocrinology of salmonids: regulatory mechanisms 
and mode of action.  Fish Physiology and Biochemistry  27, 227-242 (2002). 
Boukouvala, E., Antonopoulou, E., Favre-Krey, L., Diez, A., Bautista, J.M., Leaver, 
M.J., Tocher, D.R. and Krey, G. Molecular characterization of three peroxisome 
proliferator-activated receptors from the sea bass (Dicentrarchus labrax).  Lipids  39, 
1085-1092 (2004). 
Brandt, J.M., Djouadi, F. and Kelly, D.P. Fatty acids activate transcription of the muscle 
carnitine palmitoyltransferase i gene in cardiac myocytes via the peroxisome 
proliferator-activated receptor alpha.  Journal of Biological Chemistry  273, 23786-
23792 (1998). 
Bremer, J. The role of carnitine in cell metabolism.  In Carnitine Today. Eds: De Simine, 
C. Famularo, G. Landes Bioscience, Austin 1-38 (1997). 
Burdick, A.D., Kim, D.J., Peraza, M.A., Gonzalez, F.J. and Peters, J.M. The role of 
peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and 
differentiation.  Cellular Signalling  18, 9-20 (2006). 
Caballero, M.J., Obach, A., Rosenlund, G., Montero, D., Gisvold, M. and Izquierdo, M.S. 
Impact of different dietary lipid sources on growth, lipid digestibility, tissue fatty acid 
composition and histology of rainbow trout, Oncorhynchus mykiss.  Aquaculture  214, 
253-271 (2002). 
Chan, C.B. and Cheng, C.H.K. Identification and functional characterization of two 
alternatively spliced growth hormone secretagogue receptor transcripts from the 
pituitary of black seabream Acanthopagrus schlegeli.  Molecular and Cellular 
Endocrinology  214, 81-95 (2004). 
Chen, G.X., Liang, G.S., Ou, J.F., Goldstein, J.L. and Brown, M.S. Central role for liver 
x receptor in insulin-mediated activation of SREBP-1c transcription and stimulation of 
fatty acid synthesis in liver.  Proceedings of the National Academy of Sciences of the 
United States of America  101, 11245-11250 (2004). 
Cheng, W., Guo, L., Zhang, Z.H., Soo, H.M., Wen, C.M., Wu, W. and Peng, J.R. HNF 
factors form a network to regulate liver-enriched genes in zebrafish.  Developmental 
Biology  294, 482-496 (2006). 
Choi, K.C., Roh, S.G., Hong, Y.H., Shrestha, Y.B., Hishikawa, D., Chen, C., Kojima, M., 
Kangawa, K. and Sasaki, S.I. The role of ghrelin and growth hormone secretagroogues 
receptor on rat adipogenesis.  Endocrinology  144, 754-759 (2003). 
 27
Clarke, S.D. The multi-dimensional regulation of gene expression by fatty acids: 
polyunsaturated fats as nutrient sensors.  Current Opinion in Lipidology  15, 13-18 
(2004). 
Coe, N.R. and Bernlohr, D.A. Physiological properties and functions of intracellular fatty 
acid-binding proteins.  Biochimica Et Biophysica Acta-Lipids and Lipid Metabolism  
1391, 287-306 (1998). 
Company, R., Astola, A., Pendon, C., Valdivia, M.M. and Perez-Sanchez, J. 
Somatotropic regulation of fish growth and adiposity: growth hormone (GH) and 
somatolactin (SL) relationship.  Comparative Biochemistry and Physiology C-
Toxicology & Pharmacology  130, 435-445 (2001). 
Company, R., Calduch-Giner, J.A., Kaushik, S. and Perez-Sanchez, J. Growth 
performance and adiposity in gilthead sea bream (Sparus aurata): risks and benefits of 
high energy diets.  Aquaculture  171, 279-292 (1999). 
Cook, H.W. Fatty acid desaturation and chain elongation in eukaryotes.  In Biochemistry 
of Lipids; Lipoproteins and Membranes. Eds Vance, D.E. and Vance, J.E. Elevier, 
Amsterdam 129-152 (1996). 
Cowey, C.B. and Cho, C.Y. Nutritional-requirements of fish.  Proceedings of the 
Nutrition Society  52, 417-426 (1993). 
Cowey, C.B. and Walton, M.J. Intermediary Metabolism.  In: J.E. Halver, Editor, Fish 
Nutrition (2nd edn), Academic Press, New York 259-329 (1989). 
Cowley, D.J. and Sheridan, M.A. Insulin stimulates hepatic lipogenesis in rainbow trout, 
Oncorhynchus mykiss.  Fish Physiology and Biochemistry  11, 421-428 (1993). 
Crockett, E.L. and Sidell, B.D. Peroxisomal -oxidation is a significant pathway for 
catabolism of fatty-acids in a marine teleost.  American Journal of Physiology  264, 
R1004-R1009 (1993).   
De Celis, S.V.R., Gomez, P., Calduch-Giner, J.A., Medale, F. and Perez-Sanchez, J. 
Expression and characterization of european sea bass (Dicentrarchus labrax) 
somatolactin: assessment of in vivo metabolic effects.  Marine Biotechnology  5, 92-
101 (2003). 
De Celis, S.V.R., Rojas, P., Gomez-Requeni, P., Albalat, A., Gutierrez, J., Medale, F., 
Kaushik, S.J., Navarro, I. and Perez-Sanchez, J. Nutritional assessment of 
somatolactin function in gilthead sea bream (Sparus aurata): concurrent changes in 
somatotropic axis and pancreatic hormones.  Comparative Biochemistry and 
Physiology a-Molecular & Integrative Physiology  138, 533-542 (2004). 
De Pedro, N. and Björnsson, B.T. Regulation of food intake by neuropeptides and 
hormones.  In: Houlihan, D., Boujard, T., Jobling, M. (Eds) Food intake in fish. 
Oxford Blackwell Science 269-296 (2001). 
De Pedro, N., Martinez-Alvarez, R. and Delgado, M.J. Acute and chronic leptin reduces 
food intake and body weight in goldfish (Carassius auratus).  Journal of 
Endocrinology  188, 513-520 (2006). 
Desvergne, B., Michalik, L. and Wahli, W. Be fit or be sick: peroxisome proliferator-
activated receptors are down the road.  Molecular Endocrinology  18, 1321-1332 
(2004). 
Desvergne, B. and Wahli, W. Peroxisome proliferator-activated receptors: nuclear control 
of metabolism.  Endocrine Reviews  20, 649-688 (1999). 
 28
Desvergne, B.A., Michalik, L. and Wahli, W. Transcriptional regulation of metabolism.  
Physiological Reviews  86, 465-514 (2006)  
Dhe-Paganon, S., Duda, K., Iwamoto, M., Chi, Y.I. and Shoelson, S.E. Crystal structure 
of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid 
ligand.  Journal of Biological Chemistry  277, 37973-37976 (2002). 
Diez, A., Menoyo, D., Pérez-Benavente, S., Calduch-Giner, J.A., Vega-Rubin de Celis, 
S., Obach, A., Favre-Krey, L., Boukouvala, E., Leaver, M.J., Tocher, D.R., Pérez-
Sanchez, J., Krey, G. and Bautista, J.M. Conjugated Linoleic Acid Affects Lipid 
Composition, Metabolism, and Gene Expression in Gilthead Sea Bream (Sparus 
aurata L).  Journal of Nutrition  137, 1363-1369 (2007). 
Donohue, M., Baldwin, L.A., Leonard, D.A., Kostecki, P.T. and Calabrese, E.J. Effect of 
hypolipidemic drugs gemfibrozil, ciprofibrate, and clofibric acid on peroxisomal -
oxidation in primary cultures of rainbow-trout hepatocytes.  Ecotoxicology and 
Environmental Safety  26, 127-132 (1993). 
Dressel, U., Allen, T.L., Pippal, J.B., Rohde, P.R., Lau, P. and Muscat, G.E.O. The 
peroxisome proliferator-activated receptor / agonist, GW501516, regulates the 
expression of genes involved in lipid catabolism and energy uncoupling in skeletal 
muscle cells.  Molecular Endocrinology  17, 2477-2493 (2003). 
Drewes, T., Senkel, S., Holewa, B. and Ryffel, G.U. Human hepatocyte nuclear factor 4 
isoforms are encoded by distinct and differentially expressed genes.  Molecular and 
Cellular Biology  16, 925-931 (1996) . 
Du, Z.Y., Demizieux, L., Degrace, P., Gresti, J., Moindrot, B., Liu, Y.J., Tian, L.X., Cao, 
J.M. and Clouet, P. Alteration of 20 : 5n-3 and 22 : 6n-3 fat contents and liver 
peroxisomal activities in fenofibrate-treated rainbow trout.  Lipids  39, 849-855 
(2004). 
Escher, P., Braissant, O., Basu-Modak, S., Michalik, L., Wahli, W. and Desvergne, B.  
Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and 
refeeding.  Endocrinology  142, 4195-4202 (2001). 
Fajas, L., Debril, M.B. and Auwerx, J. Peroxisome proliferator-activated receptor-
gamma: from adipogenesis to carcinogenesis.  Journal of Molecular Endocrinology  
27, 1-9 (2001). 
FAO The state of world fisheries and agriculture 2006.   
(www.fao.org/sof/sofia/index_en.html) 1-180 (2006). 
Forman, B.M., Chen, J. and Evans, R.M. Hypolipidemic drugs, polyunsaturated fatty 
acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors 
alpha and delta.  Proceedings of the National Academy of Sciences of the United States 
of America  94, 4312-4317 (1997). 
Frohnert, B.I. and Bernlohr, D.A. Regulation of fatty acid transporters in mammalian 
cells.  Progress in Lipid Research  39, 83-107 (2000). 
Froyland, L., Helland, K., Totland, G.K., Kryvi, H. and Berge, R.K. A hypolipidemic 
peroxisome proliferating fatty acid induces polydispersity of rat liver mitochondria.  
Biology of the Cell  87, 105-112 (1996). 
Froyland, L., Lie, O. and Berge, R.K. Mitochondrial and peroxisomal -oxidation 
capacities in various tissues from atlantic salmon Salmo salar.  Aquaculture Nutrition  
6, 85-89 (2000). 
 29
Froyland, L., Madsen, L., Eckhoff, K.M., Lie, O. and Berge, R.K. Carnitine 
palmitoyltransferase I, carnitine palmitoyltransferase II, and acyl-CoA oxidase 
activities in atlantic salmon (Salmo salar).  Lipids  33, 923-930 (1998). 
Fukada, H., Ozaki, Y., Pierce, A.L., Adachi, S., Yamauchi, K., Hara, A., Swanson, P. and 
Dickhoff, W.W. Identification of the salmon somatolactin receptor, a new member of 
the cytokine receptor family.  Endocrinology  146, 2354-2361 (2005). 
Furuhashi, M., Ura, N., Murakami, H., Hyakukoku, M., Yamaguchi, K., Higashiura, K. 
and Shimamoto, K. Fenofibrate improves insulin sensitivity by reducing muscle lipid 
content via increase of fatty acid binding protein and -oxidation in muscle.  Journal 
of Hypertension  20, S56 (2002).   
Grove, T.J. and Sidell, B.D. Fatty acyl-CoA synthetase from Antarctic notothenioid 
fishes may influence substrate specificity of fat oxidation.  Comparative Biochemistry 
and Physiology B-Biochemistry & Molecular Biology  139, 53-63 (2004). 
Gutieres, S., Damon, M., Panserat, S., Kaushik, S. and Medale, F. Cloning and tissue 
distribution of a carnitine palmitoyltransferase I gene in rainbow trout (Oncorhynchus 
mykiss).  Comparative Biochemistry and Physiology B-Biochemistry & Molecular 
Biology  135, 139-151 (2003). 
Hamilton, J.A. Fatty acid transport: difficult or easy?  Journal of Lipid Research  39, 
467-481 (1998). 
Harmon, J.S., Eilertson, C.D., Sheridan, M.A. and Plisetskaya, E.M. Insulin suppression 
is associated with hypersomatostatinemia and hyperglucagonemia in glucose-injected 
rainbow-trout.  American Journal of Physiology  261, R609-R613 (1991).   
Harmon, J.S., Rieniets, L.M. and Sheridan, M.A. Glucagon and insulin regulate lipolysis 
in trout liver by altering phosphorylation of triacylglycerol lipase.  American Journal 
of Physiology  265, R255-R260 (1993).   
Harmon, J.S. and Sheridan, M.A. Effects of nutritional state, insulin, and glucagon on 
lipid mobilization in rainbow-trout, Oncorhynchus mykiss.  General and Comparative 
Endocrinology  87, 214-221 (1992a). 
Harmon, J.S. and Sheridan, M.A. Glucose-stimulated lipolysis in rainbow-trout, 
Oncorhynchus mykiss, liver.  Fish Physiology and Biochemistry  10, 189-199 (1992b). 
Hastings, N., Agaba, M., Tocher, D.R., Leaver, M.J., Dick, J.R., Sargent, J.R. and Teale, 
A.J. A vertebrate fatty acid desaturase with delta 5 and delta 6 activities.  Proceedings 
of the National Academy of Sciences of the United States of America  98, 14304-14309 
(2001). 
Hastings, N., Agaba, M.K., Tocher, D.R., Zheng, X.Z., Dickson, C.A., Dick, J.R. and 
Teale, A.J. Molecular cloning and functional characterization of fatty acyl desaturase 
and elongase cDNAs involved in the production of eicosapentaenoic and 
docosahexaenoic acids from alpha-linolenic acid in atlantic salmon (Salmo salar).  
Marine Biotechnology  6, 463-474 (2004). 
Hemre, G.I. and Sandnes, K. Effect of dietary lipid level on muscle composition in 
Atlantic salmon Salmo salar.  Aquaculture Nutrition  5, 9-16 (1999). 
Henderson, R.J. and Sargent, J.R. Lipid-metabolism in rainbow-trout (Salmo gairdnerii) 
fed diets containing partially hydrogenated fish oil.  Comparative Biochemistry and 
Physiology B-Biochemistry & Molecular Biology  78 , 557-564 (1984). 
Henderson, R.J. and Tocher, D.R. The lipid-composition and biochemistry of fresh-water 
fish.  Progress in Lipid Research  26, 281-347 (1987). 
 30
Herrmann, T., Buchkremer, F., Gosch, I., Hall, A.M., Bernlohr, D.A. and Stremmel, W. 
Mouse fatty acid transport protein 4 (fatp4): characterization of the gene and 
functional assessment as a very long chain acyl-CoA synthetase.  Gene  270, 31-40 
(2001). 
Hertzel, A.V. and Bernlohr, D.A. The mammalian fatty acid-binding protein multigene 
family: molecular and genetic insights into function.  Trends in Endocrinology and 
Metabolism  11, 175-180 (2000). 
Hihi, A.K., Michalik, L. and Wahli, W. PPARs: transcriptional effectors of fatty acids 
and their derivatives.  Cellular and Molecular Life Sciences  59, 790-798 (2002). 
Huising, M.O., Geven, E.J.W., Kruiswijk, C.P., Nabuurs, S.B., Stolte, E.H., Spanings, 
F.A.T., Verburg-Van Kemenade, B.M.L. and Flik, G. Increased leptin expression in 
common carp (Cyprinus carpio) after food intake but not after fasting or feeding to 
satiation.  Endocrinology  147, 5786-5797 (2006a). 
Huising, M.O., Kruiswijk, C.P. and Flik, G. Phylogeny and evolution of class-I helical 
cytokines.  Journal of Endocrinology  189, 1-25 (2006b). 
Inestrosa, N.C., Bronfman, M. and Leighton, F. Properties of fatty acyl-CoA oxidase 
from rat-liver, a peroxisomal flavoprotein.  Life Sciences  25, 1127-1135 (1979). 
Issemann, I. and Green, S. Activation of a member of the steroid-hormone receptor 
superfamily by peroxisome proliferators.  Nature  347 , 645-650 (1990). 
Izquierdo, M.S., Obach, A., Arantzamendi, L., Montero, D., Robaina, L. and Rosenlund, 
G. Dietary lipid sources for seabream and seabass: growth performance, tissue 
composition and flesh quality.   Aquaculture Nutrition  9 , 397-407 (2003). 
Jakobsson, A., Westerberg, R. and Jacobsson, A. Fatty acid elongases in mammals: their 
regulation and roles in metabolism.  Progress in Lipid Research  45, 237-249 (2006).  
Jiang, G.Q., Nepomuceno, L., Hopkins, K. and Sladek, F.M. Exclusive homodimerization 
of the orphan receptor hepatocyte nuclear factor-4 defines a new subclass of nuclear 
receptors.  Molecular and Cellular Biology  15, 5131-5143 (1995). 
Jobling, M. and Johansen, S.J.S. Fat distribution in Atlantic salmon Salmo salar L. In 
relation to body size and feeding regime.  Aquaculture Research  34, 311-316 (2003). 
Johnson, R.M., Johnson, T.M. and Londraville, R.L. Evidence for leptin expression in 
fishes.  Journal of Experimental Zoology  286, 718-724 (2000). 
Jordal, A.E.O., Hordvik, I., Pelsers, M., Bemlohr, D.A. and Torstensen, B.E. FABP3 and 
FABP10 in Atlantic salmon (Salmo salar Ll.) - General effects of dietary fatty acid 
composition and life cycle variations.  Comparative Biochemistry and Physiology B-
Biochemistry & Molecular Biology  145, 147-158 (2006). 
Jordal, A.E.O., Lie, O. and Torstensen, B.E. Complete Replacement of dietary fish oil 
with a vegetable oil blend effects liver and plasma lipoprotein levels in Atlantic 
Salmon (Salmo salar).  Aquaculture Nutrition  13, 114-130 (2007). 
Jordal, A.E.O., Torstensen, B.E., Tsoi, S., Tocher, D.R., Lall, S.P. and Douglas, S.E. 
Dietary rapeseed oil affects the expression of genes involved in hepatic lipid 
metabolism in Atlantic salmon (Salmo salar L.).  Jounal of Nutrition  135, 2355-2361 
(2005). 
Jump, D.B. Fatty acid regulation of gene transcription.  Critical Reviews in Clinical 
Laboratory Sciences  41, 41-78 (2004). 
Jönsson, E., Forsman, A., Einarsdottir, I.E., Kaiya, H., Ruohonen, K. and Björnsson, B.T. 
Plasma ghrelin levels in rainbow trout in response to fasting and food composition, 
 31
and effects of ghrelin on voluntary food intake.  Comparative Physiology and 
Biochemistry A  147, 1116-1124 (2007). 
Kaiya, H., Kojima, M., Hosoda, H., Moriyama, S., Takahashi, A., Kawauchi, H. and 
Kangawa, K. Peptide purification, complementary deoxyribonucleic acid (DNA) and 
genomic DNA cloning, and functional characterization of ghrelin in rainbow trout.  
Endocrinology  144, 5215-5226 (2003). 
Kangawa, K. Ghrelin: discovery and physiological significance.  Journal of 
Pharmacological Sciences  97, 3P (2005).   
Kavsan, V.M., Koval, A.P., Grebenjuk, V.A., Chan, S.J., Steiner, D.F., Roberts, C.T. and 
Leroith, D. Structure of the chum salmon insulin-like growth factor-I gene.  DNA and 
Cell Biology  12, 729-737 (1993). 
Kleveland, E.J., Ruyter, B., Vegusdal, A., Sundvold, H., Berge, R.K. and Gjoen, T. 
Effects of 3-thia fatty acids on expression of some lipid related genes in Atlantic 
salmon (Salmo salar L.).  Comparative Biochemistry and Physiology B-Biochemistry 
& Molecular Biology  145, 239-248 (2006a). 
Kleveland, E.J., Syvertsen, B.L., Ruyter, B., Vegusdal, A., Jorgensen, S.M. and Gjoen, T. 
Characterization of scavenger receptor class b, type I in Atlantic salmon (Salmo salar 
L.).  Lipids  41, 1017-1027 (2006b). 
Kojima, M. and Kangawa, K. Ghrelin: structure and function.  Physiological Reviews  85, 
495-522 (2005). 
Kurokawa, T., Uji, S. and Suzuki, T. Identification of cDNA coding for a homologue to 
mammalian leptin from pufferfish, Takifugu rubripes.  Peptides  26, 745-750 (2005). 
Le, W.P., Abbas, A.S., Sprecher, H., Vockley, J. and Schulz, H. Long-chain acyl-CoA 
dehydrogenase is a key enzyme in the mitochondrial -oxidation of unsaturated fatty 
acids.  Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids  1485, 
121-128 (2000). 
Leaver, M.J., Boukouvala, E., Antonopoulou, E., Diez, A., Favre-Krey, L., Ezaz, M.T., 
Bautista, J.M., Tocher, D.R. and Krey, G. Three peroxisome proliferator-activated 
receptor isotypes from each of two species of marine fish.  Endocrinology  146, 3150-
3162 (2005). 
Leaver, M.J., Ezaz, M.T., Fontagne, S., Tocher, D.R., Boukouvala, E. and Krey, G. 
Multiple peroxisome proliferator-activated receptor subtypes from Atlantic salmon 
(Salmo salar).  Journal of Molecular Endocrinology 391-400 (2007). 
Leaver, M.J., Tocher, D.R., Obach, A., Jensen, L., Henderson, R.J., Porter, A.R. and 
Krey, G. Effect of dietary conjugated linoleic acid (CLA) on lipid composition, 
metabolism and gene expression in Atlantic salmon (Salmo salar) tissues.  
Comparative Biochemistry and Physiology A-Molecular & Integrative Physiology  
145, 258-267 (2006). 
Leaver, M.J., Wright, J. and George, S.G. A peroxisomal proliferator-activated receptor 
gene from the marine flatfish, the plaice (Pleuronectes platessa).  Marine 
Environmental Research  46, 75-79 (1998). 
Leonard, A.E., Bobik, E.G., Dorado, J., Kroeger, P.E., Chuang, L.T., Thurmond, J.M., 
Parker-Barnes, J.M., Das, T., Huang, Y.S. and Mukerji, P. Cloning of a human cdna 
encoding a novel enzyme involved in the elongation of long-chain polyunsaturated 
fatty acids.  Biochemical Journal  350, 765-770 (2000). 
 32
Leonard, A.E., Kelder, B., Bobik, E.G., Chuang, L.T., Lewis, C.J., Kopchick, J.J., 
Mukerji, P. and Huang, Y.S. Identification and expression of mammalian long-chain 
pufa elongation enzymes.  Lipids  37, 733-740 (2002). 
Leone, T.C., Weinheimer, C.J. and Kelly, D.P. A critical role for the peroxisome 
proliferator-activated receptor alpha (PPAR) in the cellular fasting response: the 
PPAR-null mouse as a model of fatty acid oxidation disorders.  Proceedings of the 
National Academy of Sciences of the United States of America  96, 7473-7478 (1999). 
Liang, X.F., Ogata, H.Y. and Oku, H. Effect of dietary fatty acids on lipoprotein lipase 
gene expression in the liver and visceral adipose tissue of fed and starved red sea 
bream Pagrus major.  Comparative Biochemistry and Physiology A-Molecular and 
Integrative Physiology  132, 913-919 (2002). 
Lindberg, A. and Olivecrona, G. Lipoprotein lipase from rainbow trout differs in several 
respects from the enzyme in mammals.  Gene  292, 213-223 (2002). 
Londraville, R.L. and Duvall, C.S. Murine leptin injections increase intracellular fatty 
acid-binding protein in green sunfish (Lepomis cyanellus).  General and Comparative 
Endocrinology  129, 56-62 (2002). 
Londraville, R.L. and Sidell, B.D. Cold acclimation increases fatty acid-binding protein 
concentration in aerobic muscle of striped bass, Morone saxatilis.  Journal of 
Experimental Zoology  275, 36-44 (1996). 
Madsen, L. and Berge, R.K. 3-thia fatty acid treatment, in contrast to eicosapentaenoic 
acid and starvation, induces gene expression of carnitine palmitoyltransferase II in rat 
liver.  Lipids  34, 447-456 (1999). 
Maglich, J.M., Caravella, J.A., Lambert, M.H., Willson, T.M., Moore, J.T. and 
Ramamurthy, L. The first completed genome sequence from a teleost fish (Fugu 
rubripes) adds significant diversity to the nuclear receptor superfamily.  Nucleic Acids 
Research  31, 4051-4058 (2003). 
Mandard, S., Muller, M. and Kersten, S. Peroxisome proliferator-activated receptor alpha 
target genes.  Cellular and Molecular Life Sciences  61, 393-416 (2004). 
Marquardt, A., Stohr, H., White, K. and Weber, B.H.F. cDNA cloning, genomic 
structure, and chromosomal localization of three members of the human fatty acid 
desaturase family.  Genomics  66, 175-183 (2000). 
Mashek, D.G. and Coleman, R.A. Cellular fatty acid uptake: the contribution of 
metabolism.  Current Opinion in Lipidology  17, 274-278 (2006). 
Matarese, V., Stone, R.L., Waggoner, D.W. and Bernlohr, D.A. Intracellular fatty-acid 
trafficking and the role of cytosolic lipid-binding proteins.  Progress in Lipid Research  
28, 245-272 (1989). 
Maxwell, K.N., Soccio, R.E., Duncan, E.M., Schayek, E. and Breslow, J.L. Novel 
putative SREBP and LXR target genes identified by microarray analysis in liver of 
cholesterol-fed mice.  Journal of Lipid Research  44, 2109-2119 (2003). 
Mcpherson, R. and Gauthier, A. Molecular regulation of SREBP function: the INSIG-
SCAP connection and isoform-specific modulation of lipid synthesis.  Biochemistry 
and Cell Biology-Biochimie Et Biologie Cellulaire  82, 201-211 (2004). 
Mead, J.R., Irvine, S.A. and Ramji, D.P. Lipoprotein lipase: structure, function, 
regulation, and role in disease.   Journal of Molecular Medicine-Jmm  80, 753-769 
(2002). 
 33
Menoyo, D., Diez, A., Lopez-Bote, C.J., Casado, S., Obach, A. and Bautista, J.M. 
Dietary fat type affects lipid metabolism in Atlantic salmon (Salmo salar L.) And 
differentially regulates glucose transporter glut4 expression in muscle.  Aquaculture  
261, 294-304 (2006). 
Menoyo, D., Izquierdo, M.S., Robaina, L., Gines, R., Lopez-Bote, C.J. and Bautista, J.M. 
Adaptation of lipid metabolism, tissue composition and flesh quality in gilthead sea 
bream (Sparus aurata) to the replacement of dietary fish oil by linseed and soyabean 
oils.  British Journal of Nutrition  92, 41-52 (2004). 
Menoyo, D., Lopez-Bote, C.J., Bautista, J.M. and Obach, A. Growth, digestibility and 
fatty acid utilization in large Atlantic salmon (Salmo salar) fed varying levels of n-3 
and saturated fatty acids.  Aquaculture  225, 295-307 (2003). 
Menoyo, D., Lopez-Bote, C.J., Obach, A. and Bautista, J.M. Effect of dietary fish oil 
substitution with linseed oil on the performance, tissue fatty acid profile, metabolism, 
and oxidative stability of Atlantic salmon.  Journal of Animal Science  83, 2853-2862 
(2005). 
Meyer, A., Kirsch, H., Domergue, F., Abbadi, A., Sperling, P., Bauer, J., Cirpus, P., 
Zank, T.K., Moreau, H., Roscoe, T.J., Zahringer, U. and Heinz, E. Novel fatty acid 
elongases and their use for the reconstitution of docosahexaenoic acid biosynthesis.  
Journal of Lipid Research  45, 1899-1909 (2004). 
Meyer, A. and Van De Peer, Y. From 2r to 3r: evidence for a fish-specific genome 
duplication (FSGD).  Bioessays  27, 937-945 (2005). 
Michalik, L., Auwerx, J., Berger, J.P., Chatterjee, V.K., Glass, C.K., Gonzalez, F.J., 
Grimaldi, P.A., Kadowaki, T., Lazar, M.A., O'rahilly, S., Palmer, C.N.A., Plutzky, J., 
Reddy, J.K., Spiegelman, B.M., Staels, B. and Wahli, W. International union of 
pharmacology. LXI. Peroxisome proliferator-activated receptors.  Pharmacological 
Reviews  58, 726-741 (2006). 
Mommsen, T.P., Silverstein, J.T., Plisetskaya, E.M., Whittaker, L.J., Whittaker, J. and 
Conlon, J.M. Two insulins from channel catfish: purification, structures, receptor-
binding and cDNA sequences.  Fish Physiology and Biochemistry  25, 61-70 (2001). 
Morais, S., Knoll-Gellida, A., Andre, M., Barthe, C. and Babin, P.J. Conserved 
expression of alternative splicing variants of peroxisomal acyl- CoA oxidase 1 in 
vertebrates and developmental and nutritional regulation in fish.  Physiological 
Genomics  28, 239-252 (2007). 
Morgan, I.J., Mccarthy, I.D. and Metcalfe, N.B. The influence of life-history strategy on 
lipid metabolism in overwintering juvenile Atlantic salmon.  Journal of Fish Biology  
60, 674-686 (2002). 
Moya-Falcon, C., Hvattum, E., Tran, T.N., Thomassen, M.S., Skorve, J. and Ruyter, B. 
Phospholipid molecular species, beta-oxidation, desaturation and elongation of fatty 
acids in Atlantic salmon hepatocytes: effects of temperature and 3-thia fatty acids.  
Comparative Biochemistry and Physiology B-Biochemistry & Molecular Biology  145, 
68-80 (2006). 
Nanton, D.A., Lall, S.P., Ross, N.W. and Mcniven, M.A. Effect of dietary lipid level on 
fatty acid beta-oxidation and lipid composition in various tissues of haddock, 
Melanogrammus aeglefinus L.   Comparative Biochemistry and Physiology B-
Biochemistry & Molecular Biology  135, 95-108 (2003). 
 34
Nanton, D.A., Vegusdal, A., Benze-Roraa, A.M., Ruyter, B., Baeverfjord, G. and 
Torstensen, B. Muscle lipid storage pattern, composition and adipocyte distribution in 
different parts of Atlantic salmon (Salmo salar) fed fish oil and vegetable oil.   
Aquaculture  265, 230-243 (2007). 
Navarro, I., Rojas, P., Capilla, E., Albalat, A., Castillo, J., Montserrat, N., Codina, M. and 
Gutierrez, J. Insights into insulin and glucagon responses in fish.  Fish Physiology and 
Biochemistry  27, 205-216 (2002). 
Nelson, L.E. and Sheridan, M.A. Gastroenteropancreatic hormones and metabolism in 
fish.  General and Comparative Endocrinology  148, 116-124 (2006). 
Odom, D.T., Zizlsperger, N., Gordon, D.B., Bell, G.W., Rinaldi, N.J., Murray, H.L., 
Volkert, T.L., Schreiber, J., Rolfe, P.A., Gifford, D.K., Fraenkel, E., Bell, G.I. and 
Young, R.A. Control of pancreas and liver gene expression by HNF transcription 
factors.  Science  303, 1378-1381 (2004). 
Oku, H., Koizumi, N., Okumura, T., Kobayashi, T. and Umino, T. Molecular 
characterization of lipoprotein lipase, hepatic lipase and pancreatic lipase genes: 
effects of fasting and refeeding on their gene expression in red sea bream Pagrus 
major.  Comparative Biochemistry and Physiology B-Biochemistry & Molecular 
Biology  145, 168-178 (2006).  
Oku, H., Ogata, H.Y. and Liang, X.F. Organization of the lipoprotein lipase gene of red 
sea bream Pagrus major.  Comparative Biochemistry and Physiology B-Biochemistry 
& Molecular Biology  131, 775-785 (2002). 
Papasani, M.R., Robison, B.D., Hardy, R.W. and Hill, R.A. Early developmental 
expression of two insulins in zebrafish (Danio rerio).  Physiological Genomics   27, 
79-85 (2006). 
Perez-Sanchez, J., Calduch-Giner, J.A., Mingarro, M., De Celis, S.V.R., Gomez-Requeni, 
P., Saera-Vila, A., Astola, A. and Valdivia, M.M. Overview of fish growth hormone 
family. New insights in genomic organization and heterogeneity of growth hormone 
receptors.  Fish Physiology and Biochemistry  27, 243-258 (2002). 
Peters, J.M., Lee, S.S.T., Li, W., Ward, J.M., Gavrilova, O., Everett, C., Reitman, M.L., 
Hudson, L.D. and Gonzalez, F.J. Growth, adipose, brain, and skin alterations resulting 
from targeted disruption of the mouse peroxisome proliferator-activated receptor  
().  Molecular and Cellular Biology  20, 5119-5128 (2000). 
Pike, I. Eco-efficiency in aquaculture: global catch of wild fish used in aquaculture.  
Internatonal Aquafeed 38-40 (2005). 
Planas, J.V., Mendez, E., Banos, N., Capilla, E., Navarro, I. and Gutierrez, J. Insulin and 
IGF-I receptors in trout adipose tissue are physiologically regulated by circulating 
hormone levels.  Journal of Experimental Biology  203, 1153-1159 (2000). 
Plisetskaya, E.M. Some of my not so favorite things about insulin and insulin-like growth 
factors in fish.  Comparative Biochemistry and Physiology B-Biochemistry & 
Molecular Biology  121, 3-11 (1998). 
Plisetskaya, E.M., Ottolenghi, C., Sheridan, M.A., Mommsen, T.P. and Gorbman, A. 
Metabolic effects of salmon glucagon and glucagon-like peptide in coho and chinook 
salmon.  General and Comparative Endocrinology  73, 205-216 (1989). 
Price, N.T., Van Der Leij, F.R., Jackson, V.N., Corstorphine, C.G., Thomson, R., 
Sorensen, A. and Zammit, V.A. A novel brain-expressed protein related to carnitine 
palmitoyltransferase I.  Genomics  80, 433-442 (2002). 
 35
Regost, C., Arzel, J., Robin, J., Rosenlund, G. and Kaushik, S.J. Total replacement of fish 
oil by soybean or linseed oil with a return to fish oil in turbot (Psetta maxima) - 1. 
Growth performance, flesh fatty acid profile, and lipid metabolism.  Aquaculture  217, 
465-482 (2003). 
Richard, N., Kaushik, S., Larroquet, L., Panserat, S. and Corraze, G. Replacing dietary 
fish oil by vegetable oils has little effect on lipogenesis, lipid transport and tissue lipid 
uptake in rainbow trout (Oncorhynchus mykiss).  British Journal of Nutrition   96, 
299-309 (2006). 
Richards, J.G., Bonen, A., Heigenhauser, G.J.F. and Wood, C.M. Palmitate movement 
across red and white muscle membranes of rainbow trout.  American Journal of 
Physiology-Regulatory Integrative and Comparative Physiology  286, R46-R53 
(2004).   
Riley, L.G., Fox, B.K., Kaiya, H., Hirano, T. and Grau, E.G. Long-term treatment of 
ghrelin stimulates feeding, fat deposition, and alters the gh/igf-i axis in the tilapia, 
Oreochromis mossambicus.  General and Comparative Endocrinology  142, 234-240 
(2005). 
Robinson-Rechavi, M., Marchand, O., Escriva, H., Bardet, P.L., Zelus, D., Hughes, S. 
and Laudet, V. Euteleost fish genomes are characterized by expansion of gene 
families.  Genome Research  11, 781-788 (2001). 
Rollin, X., Medale, F., Gutieres, S., Blanc, D. and Kaushik, S.J. Short- and long-term 
nutritional modulation of acetyl-coa carboxylase activity in selected tissues of rainbow 
trout (Oncorhynchus mykiss).  British Journal of Nutrition  89, 803-810 (2003). 
Rosen, E.D., Sarraf, P., Troy, A.E., Bradwin, G., Moore, K., Milstone, D.S., Spiegelman, 
B.M. and Mortensen, R.M. PPAR gamma is required for the differentiation of adipose 
tissue in vivo and in vitro.  Molecular Cell  4 , 611-617 (1999). 
Ruyter, B., Andersen, O., Dehli, A., Farrants, A.K.O., Gjoen, T. and Thomassen, M.S. 
Peroxisome proliferator activated receptors in Atlantic salmon (Salmo salar): effects 
on ppar transcription and acyl-CoA oxidase activity in hepatocytes by peroxisome 
proliferators and fatty acids.  Biochimica Et Biophysica Acta-Lipids and Lipid 
Metabolism  1348, 331-338 (1997). 
Saera-Vila, A., Calduch-Giner, J.A., Gomez-Requeni, P., Medale, F., Kaushik, S. and 
Perez-Sanchez, J. Molecular characterization of gilthead sea bream (Sparus aurata) 
lipoprotein lipase. Transcriptional regulation by season and nutritional condition in 
skeletal muscle and fat storage tissues.  Comparative Biochemistry and Physiology B-
Biochemistry & Molecular Biology  142, 224-232 (2005). 
Sargent, J.R. and Tacon, A.G.J. Development of farmed fish: a nutritionally necessary 
alternative to meat.  Proceedings of the Nutrition Society  58, 377-383 (1999). 
Sargent, J.R., Tocher, D.R. and Bell, J.G. The lipids.  In Fish Nutrition. Third Edition. Ed 
Halver, J.E. and Hardy, R.W. San Diego, Academic Press 181-257 (2002). 
Seiliez, I., Panserat, S., Corraze, G., Kaushik, S. and Bergot, R. Cloning and nutritional 
regulation of a delta 6-desaturase-like enzyme in the marine teleost gilthead seabream 
(Sparus aurata).   Comparative Biochemistry and Physiology B-Biochemistry & 
Molecular Biology  135, 449-460 (2003). 
Seiliez, I., Panserat, S., Kaushik, S. and Bergot, P. Cloning, tissue distribution and 
nutritional regulation of a delta 6-desaturase-like enzyme in rainbow trout.  
 36
Comparative Biochemistry and Physiology B-Biochemistry & Molecular Biology  130, 
83-93 (2001). 
Shearer, K.D. and Swanson, P. The effect of whole body lipid on early sexual maturation 
of 1+age male chinook salmon (Oncorhynchus tshawytscha).  Aquaculture  190, 343-
367 (2000). 
Shepherd, B.S., Johnson, J.K., Silverstein, J.T., Parhar, I.S., Vijayan, M.M., Mcguire, A. 
and Weber, G.M. Endocrine and orexigenic actions of growth honnone secretagogues 
in rainbow trout (Oncorhynchus mykiss).  Comparative Biochemistry and Physiology 
A-Molecular & Integrative Physiology  146, 390-399 (2007).  
Sheridan, M.A. Regulation of lipid metabolism in poikilothermic vertebrates.  
Comparative Biochemistry and Physiology B-Biochemistry & Molecular Biology  107, 
495-508 (1994). 
Sprecher, H. Metabolism of highly unsaturated n-3 and n-6 fatty acids.  Biochimica Et 
Biophysica Acta-Molecular and Cell Biology of Lipids  1486, 219-231 (2000). 
Stubhaug, I., Froyland, L. and Torstensen, B.E. Beta-oxidation capacity of red and white 
muscle and liver in Atlantic salmon (Salmo salar L.) - Effects of increasing dietary 
rapeseed oil and olive oil to replace capelin oil.  Lipids  40, 39-47 (2005). 
Stubhaug, I., Lie, O. and Torstensen, B.E. Beta-oxidation capacity in liver increases 
during parr-smolt transformation of Atlantic salmon fed vegetable oil and fish oil.  
Journal of Fish Biology  69, 504-517 (2006). 
Stubhaug, I., Lie, O. and Torstensen, B.E. Fatty acid retention and -oxidation capacity 
in Atlantic salmon tissues (Salmo salar) fed different dietary fish- or vegetable oils: A 
life cycle study.  Aquaculture Nutrition  13, 145-155 (2007). 
Tachibana, K., Kobayashi, Y., Tanaka, T., Tagami, M., Sugiyama, A., Katayama, T., 
Ueda, C., Yamasaki, D., Ishimoto, K., Sumitomo, M., Uchiyama, Y., Kohro, T., Sakai, 
J., Hamakubo, T., Kodama, T. and  Doi, T. Gene expression profilingof potential 
peroxisome proliferator-activated receptor (PPAR) target genes in human 
hepatoblastoma cell lines inducibly expressing different PPAR isoforms.  Nuclear 
Receptor  3, 3 (2005).   
Tacon, A.G.J. Use of fish meal and fish oil in aquaculture.  Aquatic Resources,Culture 
and Development  1, 3-14 (2004). 
Tocher, D.R. Metabolism and functions of lipids and fatty acids in teleost fish.  Reviews 
in Fisheries Science  11, 107-184 (2003). 
Tocher, D.R., Leaver, M.J. and Hodgson, P.A. Recent advances in the biochemistry and 
molecular biology of fatty acyl desaturases.  Progress in Lipid Research  37, 73-117 
(1998). 
Tocher, D.R., Zheng, X.Z., Schlechtriem, C., Hastings, N., Dick, J.R. and Teale, A.J. 
Highly unsaturated fatty acid synthesis in marine fish: cloning, functional 
characterization, and nutritional regulation of fatty acyl delta 6 desaturase of Atlantic 
cod (Gadus morhua L.).   Lipids  41, 1003-1016 (2006). 
Tontonoz, P., Hu, E., Graves, R.A., Budavari, A.I. and Spiegelman, B.M. mPPAR2 - 
tissue-specific regulator of an adipocyte enhancer.  Genes & Development  8, 1224-
1234 (1994). 
Torstensen, B.E. and Stubhaug, I. Beta-oxidation of 18 : 3n-3 in Atlantic salmon (Salmo 
salar L.) hepatocytes treated with different fatty acids.  Lipids  39, 153-160 (2004). 
 37
Tschop, M., Smiley, D.L. and Heiman, M.L. Ghrelin induces adiposity in rodents.  
Nature  407, 908-913 (2000). 
Van Der Leij, F.R., Huijkman, N.C.A., Boomsma, C., Kuipers, J.R.G. and Bartelds, B. 
Genomics of the human carnitine acyltransferase genes.  Molecular Genetics and 
Metabolism  71, 139-153 (2000) . 
Veerkamp, J.H. and Vanmoerkerk, H.T.B. Fatty-acid-binding protein and its relation to 
fatty-acid oxidation.  Molecular and Cellular Biochemistry  123, 101-106 (1993). 
Volkoff, H., Eykelbosh, A.J. and Peter, R.E. Role of leptin in the control of feeding of 
goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and 
orexin A, and modulation by fasting.  Brain Research  972, 90-109 (2003).  
Wendelaar Bonga, S.E. The stress response in fish.  Physiological Reviews  77, 591-625 
(1997). 
Willumsen, N., Vaagenes, H., Lie, O., Rustan, A.C. and Berge, R.K. Eicosapentaenoic 
acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and 
upregulates 2,4-dienoyl-CoA reductase gene expression in rats.  Lipids  31, 579-592 
(1996). 
Wisely, G.B., Miller, A.B., Davis, R.G., Thornquest, A.D., Johnson, R., Spitzer, T., 
Sefler, A., Shearer, B., Moore, J.T., Miller, A.B., Willson, T.M. and Williams, S.P. 
Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty 
acids.  Structure  10, 1225-1234 (2002). 
Woods, I.G., Wilson, C., Friedlander, B., Chang, P., Reyes, D.K., Nix, R., Kelly, P.D., 
Chu, F., Postlethwait, J.H. and Talbot, W.S. The zebrafish gene map defines ancestral 
vertebrate chromosomes.  Genome Research  15, 1307-1314 (2005). 
Yeung, C.M., Chan, C.B., Woo, N.Y.S. and Cheng, C.H.K. Seabream ghrelin: cDNA 
cloning, genomic organization and promoter studies.  Journal of Endocrinology  189, 
365-379 (2006) . 
Zhang, Y.Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. and Friedman, J.M. 
Positional cloning of the mouse obese gene and its human homolog.  Nature  372, 
425-432 (1994). 
Zheng, X., Seiliez, I., Hastings, N., Tocher, D.R., Panserat, S., Dickson, C.A., Bergot, P. 
and Teale, A. Characterization and comparison of fatty acyl delta 6 desaturase cDNAs 
from freshwater and marine teleost fish species.  Comparative Biochemistry and 
Physiology B-Biochemistry & Molecular Biology  139, 269-279 (2004a). 
Zheng, X.Z., Tocher, D.R., Dickson, C.A., Bell, J.G. and Teale, A.J. Effects of diets 
containing vegetable oil on expression of genes involved in highly unsaturated fatty 
acid biosynthesis in liver of Atlantic salmon (Salmo salar).  Aquaculture  236, 467-
483 (2004b). 
Zheng, X.Z., Tocher, D.R., Dickson, C.A., Bell, J.G. and Teale, A.J. Highly unsaturated 
fatty acid synthesis in vertebrates: new insights with the cloning and characterization 
of a delta 6 desaturase of Atlantic salmon.  Lipids  40, 13-24 (2005a). 
Zheng, X.Z., Torstensen, B.E., Tocher, D.R., Dick, J.R., Henderson, R.J. and Bell, J.G. 
Environmental and dietary influences on highly unsaturated fatty acid biosynthesis 
and expression of fatty acyl desaturase and elongase genes in liver of Atlantic salmon 
(Salmo salar).  Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids  
1734, 13-24 (2005b).  
 38
Zhou, S.Y., Ackman, R.G. and Morrison, C. Storage of lipids in the myosepta of Atlantic 
salmon (Salmo salar).  Fish Physiology and Biochemistry  14, 171-178 (1995). 
 39
